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 1 Introduction 
The Gram-positive bacteria Listeria monocytogenes is the food borne etiological 
agent of Listeriosis whose manifestations include septicemia, meningitis (or 
meningoencephalitis), encephalitis and abortions (1). Although Listeriosis targets 
mainly immunocompromised populations such as pregnant women and fetus, the 
elderly, diabetics, AIDS or cancer patients, healthy individuals can also develop the 
disease, particularly if the foodstuff is heavily contaminated with highly virulent 
variants of the pathogen (2). Although almost all Listeria strains that induce sepsis, 
meningitis and encephalitis, as well as many other manifestations particularly in 
immunocompromised individuals are susceptible to most of the common antibiotics, 
the cure rate is only approximately 70% (2). Thus, if unrecognized and not treated in 
time, Listeriosis is associated with rates of fatality as high as 70 %. In addition, 
Listeriosis causes serious problems in livestock farming with 10% of animal death 
and 50% abortion being due to Listeria infection (3). Thus understanding the 
pathogenic mechanisms of L. monocytogenes is of high biomedical importance. 
Since it is well characterized and one of the most easily manipulated bacterial 
pathogens, L. monocytogenes is also a ´favourite` model pathogen for immunologists 
and microbiologists commonly used for characterizing the mammalian immune 
system and the pathogenic mechanisms of intracellular microorganisms. 
1.1 Target host cells of L. monocytogenes 
The natural route of infection with L. monocytogenes is through the gastrointestinal 
tract. Upon ingestion, bacteria invade the intestinal epithelium and /or Peyer´s 
patches, and disseminate via the bloodstream to the liver and spleen (1). Multiple 
components of the immune system are involved in protection from Listeria infection. 
Innate immunity controls pathogen replication during the first 2-3 days after infection. 
Early host defenses either eliminate the microbe or modify the slope of the growth 
curve, thereby preventing overwhelming sepsis and setting the stage for T-cell 
dependent elimination of the pathogen (4). The significance of innate immunity to L. 
monocytogenes is emphasized by the remarkable ability of mice deficient in both T-
cell and humoral immunity to control the early phase of infection (5;6). The main 
target host cells involved in the survival as well as control of L. monocytogenes are 
discussed below. 
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1.1.1 Macrophages and Dendritic cells (DCs) 
1.1.1.1 Kupffer cells 
Upon intravenous inoculation, more than 60% of the Listeria inoculum is cleared from 
the bloodstream by the liver within 10 min (7). This is due to the Kupffer cells. Kupffer 
cells are resident tissue macrophages of the liver and account for 80-90% of the total 
fixed tissue macrophages in the body (4). Kupffer cells are more dense in the 
periportal region, and are optimally located for response to systemic bacteria and 
bacterial products transported from the gut to the liver via the portal vein (8;9). Mice 
deficient in Kupffer cells exhibit significant increases in blood Listeria and decreases 
in liver Listeria 10 min after injection (4). Thus, one of the very early actions of 
Kupffer cells is to physically trap the majority of Listeria in the liver during systemic 
infections. Since more that 90% of liver bateria in the later stage of infection are 
associated not with Kupffer cells but  hepatocytes, (7;10), it has been suggested that 
Kupffer cells clear bacteria via adherence rather than phogocytosis (4). In addition, 
Kuppfer cells can also inhibit Listeria growth in by stander cells in vivo, either by 
physical interaction or secretion of soluble factors, including interleukin (IL)-6, IL-12 
IL-1α, tumor necrosis factor alpha (TNF-α) and nitric oxide (NO). These mediators 
are capable of promoting proinflammatory responses and antimicrobial activity of 
other cell populations within the liver (4;11;12). 
1.1.1.2 Resident splenic macrophages 
Rapid removal of pathogens from the circulation by secondary lymphoid organs is 
requisite for successful control of infection. Blood-borne antigens are trapped mainly 
in the splenic marginal zone. Selective depletion of marginal zone macrophages and 
marginal metallophilic macrophages caused impaired control of infection. Depletion 
these cells did not however, limit Ag presentation since Listeria-specific unimpaired 
protective T cell immunity was induced (13). Therefore, marginal zone macrophages 
and marginal metallophilic macrophages are crucial for trapping of particulate Ag but 
dispensable for Ag presentation (13). Muraille et al (14) have shown that CD8+ T cell 
priming is indeed mediated by dendritic cells rather than macrophages. However, 
since unpublished data by Jablonska et al show that Listeria infects and induces the 
expression of the CC-chemokine ligand (CCL2) in a ERT9+ splenic macrophage 
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subtype it seems possible that listerial clearence by splenic macrophages is 
mediated via direct as well as indirect mechanisms.  
1.1.1.3 Infiltrating monocytes 
The recruitment of monocytes is a feature of the inflammatory response to infection 
with Listeria and is essential for bacteria clearance. Circulating monocytes express 
CCR2, the chemokine receptor for CCL2 which as mentioned above is induced in 
macrophages by L. monocytogenes. Mice that lack CCR2 or CCL2 show a markedly 
increased susceptibility to infection to L. monocytogenes. Such mice have 
considerably lower levels of TNF-α and inducible nitric oxide oxygen synthase 
(iNOS), factors that are essential for defence against L. monocytogenes infection 
(15). The role of macrophages in bacterial clearance was also demonstrated by the 
fact that when their recruitment to the sites of infection was blocked using a 
monoclonal antibody against the complement receptor 3 (also known as CD11b-
CD18), the mice became more susceptible to Listeria infection (16). 
1.1.1.4 Dendritic cells (DCs) 
Although DCs play a major role in antigen presentation and generation of antilisterial 
T-cell responses, several studies show that DC are not a significant in vivo reservoir 
of L. monocytogenes (14;17). It is therefore proposed that the acquisition and 
presentation of Listeria antigen occurs via cross-presentation, a process that involves 
engulfment and degradation of infected cells (18). In addition to priming T cell 
responses, which are required for sterile clearance of Listeria, some subsets of DCs 
are also involved in the innate immune responses against Listeria. As mentioned 
above, TNF-α and iNOS are essential for defense against Listeria infection. Analysis 
of spleens from infected wild-type mice revealed a DC population that produces high 
levels of TNF- α and iNOS and these cells are absent from CCR2 deficient mice. 
These observation indicate that the newly discovered population of TNF- α and 
iNOS-producing DCs (known as TipDCs) is involved in the control of Listeria growth 
in vivo (19). It is worth to mentioning that CD8α+  lymphoid DCs have also been 
implicated as an important innate source of IFN-β during Listeria infection (20). 
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1.1.2 Granulocytes 
1.1.2.1 Neutrophils 
In mice, neutrophils represent approximately 15% of peripheral white blood cells. 
During bacterial infection, neutrophils efflux from the bone marrow into the peripheral 
blood, then into the sites of infection. Once localized at the site of infection, 
neutrophils may contribute to antibacterial resistance by killing bacteria, lysing 
infected host cells, stimulating apoptosis in infected cells, and / or secreting cytokines 
that suppress replication of intracellular bacteria within infected cells. 
That neutrophils play a part in resistance to Listeria infections is demonstrated by the 
fact that neutrophil-deficient mice, as well as mice unable to mobilize neutrophils 
upon infection, exhibit dramatic increases of Listeria in the liver and spleen (see 
results section and (21;22).  
1.1.2.2 Mast cells 
Mast cells are derivatives of hematopoietic progenitor cells that migrate into virtually 
all vascularized tissues, where they complete their maturation (23). Mature mast cells 
normally reside close to epithelia, blood vessels, nerves, near smooth muscle cells, 
mucus-producing glands, in the airways and in the gastrointestinal tract (23). Under 
certain circumstances, morphologically identifiable mast cells can migrate locally 
within tissues, including into epithelia (24;25). In some species, including murine 
rodents, mast cells also occur within mesothelium-lined cavities, such as the 
peritoneal cavity (23;24). 
Mast cells are known mainly for their involvement in mediating various harmful 
inflammatory reactions in the host, the best known of these being immunoglobulin E 
(IgE)-mediated immediate-type hypersensitivity reactions. Other pathologic 
processes involving mast cells include inflammatory bowel disease, autoimmune 
diseases, tissue remodeling and fibrosis (26). The contribution of mast cells to these 
chronic inflammatory conditions is exacerbated by the fact that mast cells are 
extremely long lived, with a lifespan of months to years, and because of their capacity 
to proliferate at sites of inflammation (27). 
Although the focus on mast cells has largely been in relation to allergic or 
autoimmune diseases, their role in mediating bacterial clearance at sites of infection 
is now well recognized (28). After activation, mast cells exert their biological effects 
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by releasing preformed and de novo synthesized mediators such as histamine, 
proteases, leukotrienes, prostaglandins and various cytokines, including tumor 
necrosis factor (TNF-α). Although blood monocytes, tissue macrophages and Kupffer 
cells of liver are the best known sources of TNF-α, mast cells are the only cell type 
capable of storing presynthesized TNF-α (29;30). Because of this unique capability, 
mast cells provide the only readily available source of TNF-α within peripheral tissues 
during the early course of infection. Indeed, mast cells secrete TNF-α within minutes 
of bacterial challenge (31) while the secretion of TNF-α by other cell types is greatly 
delayed by the time required to complete de novo synthesis of this potent cytokine. 
Additionally, the capacity of mast cells to ingest and kill opsonized bacteria led to the 
proposal that mast cells have a physiological function in modulating host defences 
against infectious agents (32). Most studies indicate that by effecting the release of 
appropriate amounts of TNF-α in respond to bacterial infection, mast cells benefit the 
host in facilitating early bacterial clearance. Additionally, the mast cell products 
tryptase and histamine can affect the immune system through the recruitment of 
neutrophils, as is the case for tryptase, or through effects on other immune cells, as 
is the case for histamine (23). These findings show that mast cells are essential in 
the initiation and regulation of the innate immune response.  
Although the interaction between mast cells and the innate immune system has been 
clearly established, the potential function of mast cells in the control of Listeria 
infection has so far not been investigated. As documented in this work, the present 
data do indeed show that mast cells also play a very important role in the initiation of 
antilisterail innate immune responses. 
1.1.3 Endothelial and Epithelial cells 
1.1.3.1 Enterocytes 
Upon oral Listeria infection, a study by Racz et al (33), showed that bacteria resided 
mostly in the absorptive epithelial cells of the apical area of the villi in the initial 
stages. In later phases however, the bacteria were found mostly inside macrophages 
of the stroma of the villi. This early findings already suggested that L. monocytogenes 
penetrates the host by invading the intestinal epithelium (33). This is consistent with 
the observation that L. monocytogenes is able to penetrate the apical surface of 
polarized, differentiated human enterocyte-like Caco-2 cells with a brush border (34). 
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In other studies using mice, no invasion of the intestinal villous epithelium was 
observed; instead, there was colonization of the Peyer's patches (35;36), suggesting 
that L. monocytogenes uses the M-cell epithelium as a port of entry into mice.  
1.1.3.2 Hepatocytes 
As already mentioned, once it crosses the intestinal barrier, Listeria is rapidly trapped 
from the bloodstream by the liver Kupffer cells which then pass the bacteria on to the 
hepatocytes. At 6 h after infection, hepatocytes, the preferential targets of Listeria 
infection and replication in the liver, contain more than 90% of the total number of  
Listeria organisms (4;10). Evidence supports the participation of hepatocytes in 
antibacterial defences during Listeria infection in a number of ways, including 
secretion of immunostimulatory factors, killing of Listeria, apoptosis, and interaction 
with neutrophils. Hepatocytes are also a potentially important source of chemokines 
for recruitment of effector cell populations (4). 
1.1.4 Lymphoid cells 
Although the innate immune system is important in the containment of L. 
monocytogenes sterile clearance requires the adapative immune system mediated 
mainly by T cells. Although antibodies could also be involved (37), their contribution 
is likely of minor importance.  
 
Natural Killer (NK) cells are large granular lymphocytes that play an important role in 
the innate host defences. Upon activation, NK cells exhibit lytic activity without 
restriction by MHC class I molecules and produce cytokines, especially IFN-γ. Highly 
purified human peripheral blood NK cells cultured with either live or heat killed 
Listeria lyse NK-cell-sensitive targets and produce IFN-α and TNF-α (38). Thus NK 
cells may contribute to antilisterial responses directly, by lysing infected cells, and / or 
indirectly by secreting IFN- α which activate other effector cells. 
1.1.4.1 T cells 
L. monocytogenes administered by intravenous inoculation is taken up from the 
bloodstream by splenic and hepatic macrophages. In the spleen, marginal-zone 
macrophages probably internalise circulating bacteria (13). Histological analysis of 
spleens from mice infected with L. monocytogenes showed that cells containing live, 
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cytosol-invasive bacteria migrate to the T-cell zones of the splenic white pulp within 
24 hours of infection (39). Bacterial transport to the T-cell zone is accompanied by 
substantial apoptosis in the T-cell compartment, a process that seems to require type 
I interferons (IFN-β and IFN-α (40-45). The splenic T-cell zone is where infected 
macrophages and TipDCs meet. The resulting inflammatory 'battleground', which is 
surrounded by DCs and T cells, most probably produce antigens that undergo cross-
presentation to activate CD8+ T cells. Because non-antigen-specific T cells are 
speculated to be a principal source of interferons early in infection with L. 
monocytogenes (46), it is possible that the inflammatory process in the splenic T-cell 
zones drives both the production of IFNs and the subsequent death of T cells. 
1.2 Internalization and intracellular life cycle of 
L. monocytogenes 
To cause disease, Listeria must traverse a series of formidable host barriers such as 
the intestinal epithelium and the placental and blood-brain barriers. In addition to 
uptake by phagocytes, L. monocytogenes can induce its own uptake by non-
phagocytic cells, an aspect that plays an essential role in breaching those natural 
barriers. Entry into cells involves several sets of bacterial and cell-surface 
components acting together to mediate adherence and entry. The multisystemic 
nature of listerial infection indicates that L. monocytogenes probably recognizes a 
number of different eukaryotic receptors. Such receptors include the transmembrane 
glycoprotein E-cadherin (47), the Met receptor for hepatocyte growth factor (HGF) 
(48), and components of the extracellular matrix (ECM) such as heparin sulfate 
proteoglycans (HSPG) (49) and fibronectin (50). The C3bi and C1q complement 
receptors have been reported to be involved in L. monocytogenes uptake by 
phagocytic cells (51-53). The macrophage scavenger receptor was shown to bind L. 
monocytogenes lipoteichoic acids and hence may also be involved in Listeria-
macrophage interactions (54). 
As mentioned above, the natural route of infection with L. monocytogenes is through 
the gastrointestinal tract. L. monocytogenes infects intestinal epithelial cells in a 
process that requires the interaction of Internalin A (encoded by InlA) which is 
expressed at the cell surface of the bacteria, with epithelial cadherin (E-cadherin), 
which is expressed at the surface of epithelial cells (55). Although L. monocytogenes 
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has a broad host range, the efficiency with which intestinal epithelial cells from 
different mammalian species are infected varies. Mice for example, are relatively 
resistant to intestinal infection with L. monocytogenes because of a single amino-acid 
difference between human and mouse E-cadherin (56;57).  
Bacteria traverse the epithelial-cell layer and disseminate in the bloodstream to other 
organs, such as the spleen and liver, where they are internalised by splenic and 
hepatic macrophages. In the liver, L. monocytogenes enters hepatocytes by 
expressing another surface protein, Internalin B (encoded by InlB) which binds the 
hepatocyte growth factor (HGF) receptor present at the cell surface of hepatocytes 
(48).  
 
 
Figure 1.1. Life cycle of Listeria monocytogenes. 
After cellular invasion, L. monocytogenes escapes the phagosome by secreting 
listeriolysin O (LLO), a virulence factor that destroys the phagosomal membrane (58). 
In some cell types, such as HeLa cells, escape from the vacuole to the cytosol can 
be mediated by listerial phospholipases (encoded by plcA and plcB), independently 
of LLO (59;60). LLO is to a large extent the main focus of the present work and as 
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discussed in more details below, LLO besides facilitating vesicular escape, plays 
multiple roles in pathogenesis of Listeria. 
Motility of the bacteria in the cytosol is mediated by the surface protein ActA 
(encoded by actA), which nucleates polymerization of actin into polarised actin tails 
that propel the bacteria towards the membrane where they get enveloped into 
filopodium-like structures (also called `listeriopods´), which are recognized and 
engulfed, by adjacent cells. Through the co-operative action of LLO and, the Listeria 
phospholipases the bacteria consequently free themselves from the resultant double-
membrane vacuoles into the adjacent cells (33;61;62). Thus, by direct cell-to-cell 
spread, bacteria disseminate within host tissues while protected from antibodies or 
complement. 
1.3 Role of Listeriolysin in infection 
Listeriolysin O (LLO), the pore-forming toxin of Listeria monocytoneges, which to a 
large extent is the main focus of the present study, is considered to be the most 
important virulence factor of L. monocytogenes. LLO is a member of Cholesterol-
Dependent-Cytolysins (CDCs), a large family of toxins currently comprising 23 toxins 
produced by five different genera of Gram-positive bacteria. These toxins commonly 
bind to cholesterol in the host cell membrane, and share a considerable degree of 
structural similarity suggesting that they all derive from a common ancestral gene. 
Monomers of these toxins bind to cholesterol-containing membranes, in which they 
oligomerize to form ring or arc-shaped oligomeric complex pores composed of 50-80 
subunits. These large pores of at least 20-30 nm in diameter (63-66) disrupt host cell 
membranes thus allowing the transit of bacteria from one compartment to the other 
within the cell.  
Although breaking membrane barriers to allow cytosolic invasion by L. 
monocytogenes is the original function for which the initial studies were ascribed to, 
accumulating evidence now indicate that LLO is a multifunctional virulence factor with 
many important roles in the host-parasite interaction. Exogenous and endogenous 
exposure to LLO may induce a number of host cell responses, such as cell 
proliferation and focus formation in transfected fibroblasts (67), activation of the Raf–
Mek–mitogen-activated protein (MAP) kinase pathway in epithelial cells (68;69), 
mucus exocytosis induction in intestinal cells (70), modulation of bacterial 
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internalisation via calcium signalling (71;72), induction of cytokine expression in 
macrophages (73;74), degranulation and leukotriene formation in neutrophils (75), 
induction of apoptosis (42;76), NF-κB activation and expression of cell adhesion 
molecules in infected endothelial cells (1;77). 
The significance of the host responses triggered by LLO is underscored by the fact 
that mutant strains lacking LLO are not only avirulent (as mentioned above) but that 
they are also incapable of generating protective immunity in mice. Substitution of LLO 
with the analogous members of the cholesterol dependent cytolysins (CDCs) such as 
ivanolysin O (ILO) and an attenuated variant of pefringolysin (PFO) allowed normal 
phagosomal escape and survival in macrophages in vitro but failed to compensate 
fully for the functions of LLO since such bacteria showed a limited in vivo survival. 
(78; 79). Thus, despite the shared features, LLO possesses unique pathogenic 
properties that cannot be made up for by the other CDCs Since these toxins can 
allow efficient phagosomal escape of Listeria, the limited in vivo survival of such 
bacterial variants could probably be due an inability to trigger particular host cells 
responses necessary for survival.  
1.3.1 What are the mechanisms of signal induction by LLO?  
The mechanisms by which LLO trigger such multiple and diverse cellular responses 
such as those exemplied above, are still poorly understood. Some of the responses 
such as mucus exocytosis in intestinal cells, are clearly dependent on the pore 
forming activity of LLO (70). Recent data suggest that LLO induces calcium signalling 
in host cells (71;80). Since Ca2+ oscillation modulates several signalling processes, 
the data may in part explain the broad spectrum of cellular responses induced by 
LLO. However, pore formation per se does not explain it all. Inhibition of pore 
formation by pre-incubation of LLO with cholesterol does not affect its ability to bind 
and induce particular signals in target host cells (66;81;82). This implies that LLO has 
multiple biological activities and can trigger signalling via mechanisms that are 
independent of pore formation.  
To understand the pore dependent and pore independent mechanisms, induction of 
calcium fluxes by LLO and the role of the cholesterol rich membrane microdomains 
(lipid rafts) have been investigated in this work. Section 1.4 gives a brief introduction 
into calcium signalling by bacterial pathogens components while section 1.5 give a 
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general introduction into lipid rafts and their role in signal transduction and in host-
pathogen interaction.  
In addition to the signals triggered by LLO, L. monocytogenes can also trigger signals 
independently of LLO. To investigate these mechanisms, the role of toll-like receptors 
(TLRs), in the induction of proinflammatory signals by L. monocytogenes was also 
investigated. Section 1.6 gives a general introduction into signal transduction via 
these receptors. 
1.4 Induction of calcium signalling in host cells during 
interaction with bacterial pathogens 
Ca2+ is a ubiquitous intracellular messenger, controlling a diverse range of cellular 
processes, such as metabolism, gene transcription, cell proliferation, fertilization, 
muscle contraction, apoptosis, exocytosis and cytoskeletal reorganization (83). In 
addition, induction of cellular calcium flux has emerged as a widespread mechanism 
by which many pathogenic bacteria influence host cells. Among the mentioned Ca2+ 
dependent processes, alteration of the host`s metabolism, induction of apoptosis and 
the control of gene expression, especially that leading to the expression and 
secretion of proinflammatory mediators as well as cytoskeletal reorganization, are of 
particular significance during bacterial infection. More and more studies now show 
that the mechanisms of Ca2+ signal induction are as multiple and diverse as the 
virulence factors in question. The list in Table 1 shows a few examples of bacterial 
pathogens and the respective virulence factors responsible for calcium signalling in 
host cells.  
Because LLO is of particular relevance in the present studies, this introduction will 
dwell more on induction of Ca2+ fluxes by pore forming toxins.  
Ca2+ signalling by pore forming toxins has been ascribed to the influx of extracellular 
Ca2+ as well as the release from intracellular Ca2+ stores (80;84). In most cases, 
induction of Ca2+ influx by pore-forming toxins occurs largely due to the passive 
diffusion of ions via the toxin transmembrane pores. This is especially true for the 
large non-selective pores formed by the Cholesterol Dependent Cytolysins (CDCs) 
such as LLO. Because of their large size, such pores can allow the passage of ions 
and macromolecules into and out of the cell (85). In addition to passive diffusion, 
calcium signalling by some pore forming toxins has been shown to involve the 
opening of membrane Ca2+ channels.  
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Ca2+ influx as a result of the opening of Ca2+ channels by a pore-forming toxin has 
best been demonstrated for the staphylococcal leukotoxins. It is thought that the 
leukotoxins bind to either a receptor linked to a divalent cation-selective channel, or 
to the channel itself thus activating it. The leukotoxins then open a second pathway 
by insertion into the membrane and subsequent formation of aspecific pores allowing 
influx of other molecules (86). 
Organism Virulence factor Mechanism 
Escherichia coli α-hemolysin (HlyA) Ca
2+ influx and release from intracellular 
stores 
 Heat-labile enterotoxin (Etx) Ca2+ influx 
 Heat-stable enterotoxin B (STB) Ca2+ influx 
 Heat-stable enterotoxins A (STa) Release from intracellular Ca2+stores 
 Cytolysin A    Ca
2+ influx and release from intracellular 
stores 
Vibrio cholerae Non-agglutinable Sta (NAG-ST) Release from intracellular Ca2+stores 
 Cholera toxin B Ca2+ influx 
Bacillus anthracis Anthrax edema factor (EF)  Ca2+ influx 
Clostridium difficile  Toxin B Ca2+ influx  
Clostridium perfringens  Enterotoxin, α-toxin Ca2+ influx  
 α-toxin and Perfringolysisn O Ca2+ influx 
Shigella flexneri  Type III effectors Release from intracellular stores 
Salmonella enteritidis Type III effectors Release from intracellular stores 
 FliC flagellin Release from intracellular stores 
Pseudomonas aeruginosa Type III effectors(ExoU) and type IV pili Release from intracellular stores 
 FliC flagellin From intracellular stores 
Staphylococcus aureus  Staphylococcal α-toxin Ca2+ influx and from intracellular stores, 
 Bicomponent leukotoxins of γ-hemolysins(HlgA, HlgB, HlgC) Ca
2+ influx 
Aeromonas hydrophila aerolysin Ca
2+ influx and release from intracellular 
stores 
Neisseria gonorrhoeae  Membrane porin (PorB) Ca2+ influx 
Yersinia enterocolitica  Heat stable enterotoxin (Y-STa) Ca2+ influx 
 γ-Phospholipase C Release from intracellular stores 
Mannheimia haemolytica Leukotoxin (LKT) Ca
2+ influx and release from intracellular 
stores 
Group A Streptococcus (GAS) Streptolysin O (SLO) Ca2+ influx 
Listeria monocytogenes Listeriolysin O Ca2+ influx 
 PosphatidyIinositol phospholipase C (PI-PLC) Release from intracellular stores 
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Table 1. Bacterial pathogens and virulence factors that induce calcium signalling in host cells. 
Compiled from TranVan et al (84) 
A common feature in Ca2+ signalling by Gram-negative bacteria such as 
Pseudomonas aeruginosa, Shigella flexineri, Salmonella enteritidis, and Helicobacter 
pylori is that Ca2+ signalling is dependent on the delivery of the effector via the type III 
and / or IV apparatus (84). Since the targeting of effectors into the host cell cytosol by 
the type III apparatus depends on the formation of a pore within host cell 
membranes, the mechanism underlying the elevation of cytosolic Ca2+ by this 
mechanism presents a close similarity with some pore forming toxins such as the 
CDCs. In fact, based on several recent studies, CDCs are now considered to be the 
equivalent of type III secretion apparatus in Gram-positive bacteria for delivering 
molecules into the host cell (87). In that respect, LLO has been found to play the 
accessory role of delivering PI-PLC - a L. monocytogenes phospholipase, into the 
cytosol where it ultimately triggers the release of Ca2+ from intracellular stores via the 
generation of Inositol triphosphate (IP3) (88). Thus, LLO plays at least two roles in the 
induction of Ca2+ signals; (1) directly inducing the influx of Ca2+ (71;88), (2) 
modulating Ca2+ release from intracellular stores by allowing PI-PLC access to the 
host´s phosphatidylinostitol diphosphates. 
As illustrated, the fact that several bacterial components participate in the induction 
or modulation of these responses presents a level of complexity in delineating the 
mechanisms underlying bacteria-induced Ca2+ signalling. This is further complicated 
by the fact that Ca2+ signal induction even by a single bacterial component, could 
involve multiple signalling pathways. Therefore, despite the recent advances, the 
precise mechanisms underlying the induction of Ca2+ responses by LLO, let alone L. 
monocytogenes, remain by and large uncharacterized. 
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1.5 Role of lipid rafts in the interaction of pathogens with 
hosts cells 
The “fluid mosaic” theory originally proposed by Singer and Nicholson (89) is still the 
text book model that explains the architecture of the plasma membrane. According to 
this model, the plasma membrane is a two-dimensional lipid solvent in which packing 
is loose and lateral diffusion is relatively rapid. The implications of such a model is 
that all plasma membrane proteins are uniformly dispersed in the lipid solvent, akin to 
`icebergs in a sea of lipids. In the past two decades however, many independent 
investigators have acknowledged that the plasma membrane is not as homogeneous 
as proposed (90). Biophycisists find that lipids in the bilayer model exist in several 
phases ranging from the quasi-solid gel phase on one extreme, to the fluid mosaic or 
fluid-crystalline (Ic ) phase on the other. In the quasi-solid gel phase, phospholipids 
with saturated hydrocarbon chains such as sphingolipids (glycosphingolipids and 
sphingomyelins) pack tightly with cholesterol to form lateral assemblies within the 
bilayer onto which specific proteins attach. These assemblies are now generally 
referred to as membrane microdomains. In resemblance to `vessels floating in a sea 
of lipids´, the analogous term lipid rafts has recently been adapted to refer to such 
microdomains. 
1.5.1 Conception of the raft hypothesis 
The turning point in the way the plasma membrane structure is viewed came with the 
conception of the raft hypothesis (91-95). It was formulated based on studies carried 
out on epithelial cell polarity (96). In epithelial cells, plasma membranes are distinct 
into apical and basolateral domains, with the former being enriched in sphingolipids 
and the latter in glycerolipid phosphatidylcholine (97). Proteins with 
glycosylphospatidyl inositol (GPI) anchors were also shown to be expressed 
exclusively on the apical surface of several epithelial cell lines (98). Studies on the 
delivery of newly synthesised lipids in such cells revealed that a simple 
glycosphingolipid was preferentially transported to the apical membrane (97;99;100). 
To explain this preferential delivery, Simons and colleagues (99) proposed that 
glycosphingolipid-rich microdomains that also contain proteins, form within the 
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exoplasmic leaflet of the Golgi apparatus and become packaged into vesicles for 
apical transportation.  
The initial direct experimental support for the raft model came from the behaviour of 
GPI-anchored proteins (101). These proteins were shown to partition into detergent-
resistant membranes (DRMs) enriched in glycosphingolipids with the exclusion of 
basolateral marker proteins. In addition, partitioning of these proteins into DRMs 
occurred in the Golgi complex, thus implying that protein-sphingolipid microdomains 
form in the Golgi apparatus and are exported to the plasma membrane. As described 
in the next sections, these microdomains may also be found in other vesicles. 
Cumulatively, these studies suggested that GPI anchors and association with the 
DRMs could target proteins to the apical membranes. However, in the meantime, it is 
clear that other membrane microdomain (raft) targeting signals exist (see below). 
Although scientists are now just beginning to unravel the dynamics of the 
Glycosphingolipid–protein microdomains (lipid rafts), caveolae - small invaginations 
of a similar glycolipid composition, found on the surface of many cell types, had 
already been discovered by Palade and Yamada  in the 1950s. As will be covered in 
more detail  below, caveolae share many features with the classical lipid rafts. For 
instance, it was shown that caveolin (the main structural protein of caveolae) co-
purified with DRMs and is also present in the post-Golgi transport vesicles (102). One 
outstanding question that emerged from these observations was: what functional 
attributes besides the shared glycolipid compositions, could the two share? Before 
any precise function was ascribed to the lipid rafts, suggestive evidence to the effect 
that caveolae may be involved in endocytosis (103), transcytosis (104) and signalling 
(98;105) was already in existence. Therefore, given these similarities with caveolae in 
terms of biogenesis and the glycolipid compositions, the putative functions of rafts, 
was simply a consequence of logical association. Assimilation of all the above lead to 
the formulation of the raft model (Figure 1.2) proposed by Simons and colleagues 
(94). Although it is still under intense debate (106;107), this model is the current 
unifying concept on the dynamic organizational structure and function of the lipid 
bilayer.  
According to this model, sphingolipids associate with one another, probably by weak 
interactions between their carbohydrate heads. The sphingolipid head groups occupy 
larger excluded areas in the plane of the exoplasmic leaflet than do their 
predominantly saturated lipid hydrocarbon chains.  
1. Introduction  16 
 
Figure 1.2. Diagram Summarizing the Membrane Organization of Lipid raft and Caveolae. The 
rafts (red) segregate from the other regions (blue) of the bilayer in the exoplasmic leaflet. The blue 
region (predominantly enriched in phosphatidylcholine) has a different organization from that of the 
rafts. (a) Rafts contain proteins attached to the exoplasmic leaflet of the bilayer by their GPI anchors. 
Acylated proteins (the Src-family kinase Yes) are shown binding to the cytoplasmic leaflet, while the 
influenza virus proteins neuraminidase and haemagglutinin (HA) associate with rafts through their 
transmembrane domains. (b) The lipid bilayer in rafts is asymmetric, with sphingomyelin (red) and 
glycosphingolipids (red) enriched in the exoplasmic leaflet. Glycerolipids such as phosphatidylserine 
and phosphatidylethanolamine (green) are enriched in the cytoplasmic leaflet while cholesterol (grey) 
is present in both leaflets and fills the space under the head groups of sphingolipids or extends the 
interdigitating fatty acyl chain in the opposing leaflet. (c) Caveolae are formed by self-associating 
caveolin molecules forming a hairpin loop in the membrane. Interactions with raft lipids may be 
mediated by binding to cholesterol and by acylation of C-terminal cysteines. (94) 
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Any voids between associating sphingolipids are filled by cholesterol molecules 
which function as spacers (Figure 1.2b). The close-packed sphingolipid–cholesterol 
clusters behave as assemblies within the exoplasmic leaflet, whereas the intervening 
fluid regions are occupied by unsaturated phosphatidylcholine molecules (Figure 
1.2a). Glycosphingolipids that carry long fatty acids which are amide-bonded to the 
sphingosine base interdigitate with the cytoplasmic leaflet of the bilayer. Since 
cholesterol is present in both leaflets, it was suggested that it functions as a spacer in 
the cytoplasmic leaflet as well, filling voids created by interdigitating fatty acid chains 
(Figure 1.2b). 
Although the formation of membrane microdomains in the exoplasmic leaflet can be 
explained by phase separation of sphingolipids and cholesterol, the lipid composition 
and the organization in the corresponding cytoplasmic leaflet has not been defined. 
Besides cholesterol, it probably also carry mainly saturated fatty acid chains to 
optimise packing. Individual lipids may also move in and out of the rafts, explaining 
why sphingolipid–cholesterol clustering is difficult to detect spectroscopically. 
1.5.2 Physico –chemical properties of rafts 
One reason why it has been difficult to prove that rafts exist in cells is their size. By 
use of flourescence resonance energy transfer (FRET), the size of individual rafts 
has been estimated to be smaller than 10 nm in diameter (108-110). This size 
precludes detection by standard light microscopy. However, if rafts are cross-linked 
with antibodies or lectins in living cells, they then cluster together in such a manner 
that raft and non-raft components separate into micron-sized quilt-like patches that 
can be visualized microscopically (111;112). Oddly, the strongest experimental 
support for the existence of rafts came from seemingly unrelated findings, namely 
their high melting temperature (Tm) and insolubility in non-ionic detergents (113). 
Plasma membranes are partially resistant to solubilization by non ionic detergents 
like Triton X-100 in the cold (113) or like Polyoxyethylene ether at physiological 
temperatures (114). Membrane fragments extracted with these detergents float to low 
density during sucrose gradient centrifugation and are enriched in raft associated 
proteins and lipids. This has provided a simple means of identifying possible raft 
components. As a consequence, rafts are also referred to as: Detergent-Resistant 
Membranes (DRMs), Detergent-Insoluble Glycolipid-rich domains (DIG), Detergent–
Insoluble Membranes (DIM) and Low-density Triton-insoluble (LDTI) complexes. 
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Despite the ease and usefulness of non-ionic detergent extraction, this method is not 
without its shortcomings. For instance, milder detergents such as octylglucoside, will 
solubilize lipid rafts (115). Another problem with detergent extraction is that the 
original subcellular locations of DRMs are unknown. Moreover, association of a 
protein with the raft may be so weak that it is solubilized by the detergent. 
Association of some raft proteins with the cytoskeleton can also preclude their 
detection in the DRMs since they do not float after detergent extraction. Changes in 
detergents and extraction conditions have also been shown to produce contrasting 
results (116;117). 
1.5.3 Criteria for association of proteins with rafts 
One of the most important properties of lipid rafts is that they can, constitutively or 
inducibly, include or exclude proteins to variable extents. Many of the associated 
proteins are linked to saturated acyl chains, which is likely to make them prefer an 
ordered environment. Proteins can be linked to saturated acyl chains in two ways; 
either in the form of a GPI anchor (118;119) or through myristylation and 
palmitoylation. For GPI-anchored proteins, the GPI anchors, usually two, determines 
raft association (120). The importance of acylation in the preferential targeting to rafts 
has been shown most clearly for the Src family nonreceptor protein tyrosine kinases 
(121;122). With a few exceptions (123), most groups have found that association of 
these kinases with rafts require dual modification by both myristate and palmitate 
(122;124) Based on these findings, acylation is considered to be a raft targeting 
signal for a wide range of proteins. Though GPI-anchorage and acylation are the only 
known signals for raft targeting, other signals must exist as some raft proteins contain 
neither modifications (113). For instance, although most transmembrane proteins 
generally appear to be excluded from lipid rafts, some do show rafts association. 
Most of the notable exceptions include, a fraction of linker of activated T cells (LAT) 
(125), CD4 and CD8 in T cells, integrins in myeloid cells, CD44, and CD26 in 
lymphocytes, CD36 in platelets (126) and the influenza virus proteins neuraminidase 
(NA) and haemagglutinin (HA). 
1.5.4 Caveolae 
Different classes of rafts with specific protein composition have been shown to exist 
in mammalian cells (114). For instance, caveolae are one distinct subset of rafts. 
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These flask-shaped plasma membrane invaginations are formed from classical 
sphingolipid rafts by polymerisation of caveolin – hairpin-like palmitoylated integral 
membrane proteins. When caveolin is integrated into the microenvironment of a lipid 
raft, these microdomains invaginate and form caveolae, i.e. 50-100 nm flask-shaped 
structures located at or near the plasma membrane. Originally, caveolae were 
believed to be found only in non-hematopoietic cells. However, in recent years, this 
notion is proving to be null and void because, (i) caveolae have been found to be 
pleiomorphic with vesicular, flat or tubular forms also existing within cells (127); (ii) 
caveolins have been found in raft entities in virtually all cell types examined, including 
hematopoietic cells such as macrophages, dendritic cells and  mast cells (128). Thus, 
caveolae are pleomorphic lateral assemblies of a distinct group of molecules 
including cholesterol, a 22-kDa protein caveolin-1 and various glycolipids and GPI 
anchored proteins (129). In recent years caveolae have been implicated in several 
cellular processes including vesicular trafficking, and signal transduction (130). 
1.5.5 Cellular and subcellular distribution of rafts 
DRMs have been isolated from almost all mammalian cell types. Immature 
oligodendrocytes (131) and immature hippocampal neurons  are exceptions in that 
they are poor sources of DRMs. However, as hippocampal neurons mature, their 
sphingomyelin content and therefore their ability to produce DRMs, increases (113). 
DRMs have not been well identified in other eukaryotes, although they have been 
isolated from Sacharomyces cerevisiae (132). 
The distribution of lipid rafts over the cell surface depends on the cell type. In 
polarised epithelial cells and neurons, lipid rafts accumulate in the apical and axonal 
membranes respectively. Basolateral and somato-dendritic membranes also contain 
rafts, but in smaller amounts. In contrast, caveolae are mainly present on the 
basolateral side of epithelial cells (133) facing the blood supply. The functional 
significance as well as the underlying mechanisms of this aberrant distribution is still 
a puzzle. In lymphocytes and fibroblasts, rafts are distributed over the cell surface 
without any obvious polarity (110).  
The lipid raft dogma was drafted largely based on the morphological characterisation 
of the sphingolipid-cholesterol assemblies concentrated in the exoplasmic leaflet of 
the plasma membrane. Nonetheless, it is generally assumed that rafts exist in both 
the external and internal leaflets of the membrane, and that they overlap so that they 
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are coupled functionally and structurally. The two monolayers of the plasma 
membrane of eukaryotic cells have different chemical compositions. This out-of-
equilibrium situation is maintained by the activity of lipid translocases, which 
compensate for the slow spontaneous transverse diffusion of lipids. Thus, although 
linked, rafts in the outer leaflet, corresponding to domains enriched in sphingomyelin 
and cholesterol, cannot be identical to those in the inner cytoplasmic leaflet. Brown & 
colleagues (134) did however observe that some glycerophospholipids may also 
participate in raft formation, a property that could be critical in the formation of rafts in 
the inner leaflet. Intimations that rafts also occur in the cytoplasmic leaflet have been 
drawn indirectly. For example, the fact that Src-family kinases are present in DRMs, 
although their acyl chains have access only to the inner leaflet, suggests that rafts 
exist in the cytoplasmic leaflet (113). Similarly, by using a cyan-fluorescent protein 
(CFP) targeted to inner plasma membrane rafts of Jurkat T cells, Gri and co-workers 
have found that raft domains at the outer and inner leaflets are physically coupled 
and that this coupling requires cholesterol (135).  
Biological rafts are in general of nm scale, and almost certainly differ in size and 
stability in inner and outer monolayers. Any coupling between rafts in the two leaflets, 
should it occur, is considered to be transient and dependent upon not only the 
properties of lipids, but on transmembrane proteins within the rafts as well (136). 
Although lipid rafts are localized mainly at the level of the plasma membrane, they 
can also form within integral membrane compartments, such as the Golgi apparatus 
(137) and endocytic vesicles. As noted earlier, the biogenesis of rafts is initiated at 
the Golgi apparatus. The assembly of the raft proteins with sphingolipid-cholesterol 
microdomais first occurs at this level before moving to the plasma membrane (101). 
However, lipid raft trafficking does not end with cell surface delivery. Rafts have been 
shown to be endocytosed continuously from the plasma membrane (95). From early 
endosomes, rafts recycle either directly back to the cell surface or return indirectly 
through recycling endosomes, which could also deliver them to the Golgi (138;139). 
1.5.6 Lipid rafts in signal transduction 
The most important role of rafts at the cell surface may be their function in signal 
transduction. One way to consider signalling through rafts is that rafts form platforms 
that concentrate or separate specific proteins in a unique signalling entity. The best 
evidence for the involvement of rafts in signalling came from studies on FcεRI, the 
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receptor for IgE on basophils and mast cells. IgE binds constitutively to cell-surface 
FcεRI. When antigens are recognised by the bound IgE, FcεRIs are induced to 
aggregate. Aggregation of these receptors activates the associated Src-family kinase 
Lyn, initiating a signalling cascade that culminates in degranulation. Studies by 
Holowka and co-workers showed that aggregation of the FcεRIs led to its recruitment 
into DRMs to be phosphorylated by Lyn. This was interfered with by depletion of 
surface cholesterol. (140; 141). These and many other subsequent findings have 
provided the strongest evidences to date that rafts do indeed form under 
physiological conditions. Apart from the FcεRI, rafts have also been shown to be 
involved in several other signalling processes. These include, the T-cell receptor 
(TCR), B-cell receptor (BCR), epidermal growth factor (EGF), insulin receptor, 
intergrins, Ephrin and EGF receptors, the H-Ras, glial-cell derived neurotrophic factor 
(GDNF), endothelial nitric oxygen synthase (eNOS) and the Hedgehog signalling 
pathways (95;114;142-146) just to mention a few. Since Mast cells are of particular 
relevance to the present study signal transduction in this cell type has been given 
more detailed coverage below.  
How do lipid rafts regulate signalling? Although appealing working hypotheses have 
been put forward, there are still unanswered questions on how receptors signal 
through rafts. For instance, it has been observed that clustering or ligation of cell-
surface GPI-anchored proteins can trigger the activation of Src-family kinases in the 
cytoplasm (95;147;148). Since neither protein penetrate the bilayer, how GPI-
anchored proteins send information across the membrane still remains a mystery. A 
plausible scenario is that GPI-anchored proteins may bind to elements cis to 
transmembrane proteins, thus allowing the transmission of signals across the 
membrane. Another possibility is based on the observation that GPI-anchored 
proteins associate with glycosphingolipids. Since glycosphingolipids carry long fatty 
acid chains that can interdigitate with the cytoplasmic leaflet, it is reasonable to 
imagine that GPI anchored proteins may exploit them to engage in an indirect 
communication with the signalling components in the cytoplasmic leaflet. The 
uncertainties on the precise mechanisms of cytoplasmic /exoplasmic raft interactions 
notwithstanding, a number of models (Figure 1.3) to explain how extracellular signals 
are transmitted through rafts have been put forward by Simons K & Toomre (95). 
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Figure 1.3. Model 1: How signalling can be initiated in single rafts.  Receptors associated with 
rafts at steady state could be induced to aggregate upon ligand binding thus leading to activation of 
signals (Fig 1.3Aa), Alternatively, individual receptors with weak affinity for rafts could oligomerize on 
ligand binding and this would lead to an increase in residency time in rafts (Fig 1.3Ab). Model 2: How 
raft clustering induces signalling. Activated receptors could recruit cross-linking proteins that 
associate with other rafts, resulting in rafts coalescence (Fig 1.3B). Through formation of a raft cluster, 
a network of interactions between adaptors, scaffolds and anchoring proteins would be built up to 
organize the signalling complex in space and time. This signalling complex would be insulated within 
raft clusters from the surrounding liquid-crystalline lipid matrix (Ice). The formation of clustered rafts 
would lead to amplification through the concentration of signalling molecules, as well as exclusion of 
unwanted modulators. 
The TCR is one of the classic examples of how rafts aggregation induces signalling. 
This receptor is only weakly associated with detergent resistant membranes (Drums), 
both in non-stimulated Jurket T cells and in thymocytes (125;149). Following TCR 
engagement, its association with DRMs increases. This DRM-association correlates 
with the phosphorylation of immunoreceptor tyrosine based activation motives 
(ITAMs) in the TCR-ζ chains. Phosphorylation of ITAMs sparks a chain of 
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phosphorylation events that lead to the recruitment and exclusion of particular 
proteins. This raft/non raft partitioning initiates the formation of the “immunological 
synapse” (IS) in which negative modulators such as CD45, and CD43 are excluded 
(150;151).  
The interactions that drive raft assembly are dynamic and reversible. Raft clusters 
can be disassembled by negative modulators and /or by removal of raft components 
from the cell surface by endocytosis (95). The size of rafts in relation to signalling is 
still a hotly debated issue. For instance, whereas there are strong experimental data 
to argue for the aggregation of rafts into large assemblies, there are counter 
arguments why domains should be much smaller in biological membranes. To have 
very large rafts would seem to negate the effectiveness of rafts as a dispersed, 
regulatory structure. In natural membranes therefore, aggregation and/or 
disassembly of rafts could be under regulatory factors such as the cytoskeleton to 
provide sizable domains with appropriate functionality (152). 
1.5.7 Role of rafts / caveolae in infection 
Since the discovery of lipid rafts less than two decades ago, scientists are now 
coming to terms with the realisation that after all, these structures were already 
discovered millions of years ago by microbes. During these years, pathogenic 
microbes have evolved a myriad of strategies for communication and coexistence 
with their target host. The importance of rafts in that respect is highlighted by their 
enrichment in signalling molecules that make them a natural target for microbes to 
communicate with the host. Lipid rafts are also known to undergo fission from the 
plasma membrane, mediating a form of endocytosis that is different from clathrin-
coated pit internalisation (153). Hence, microbial agents might also favour interaction 
with lipid rafts as a potential way to enter host cells. 
To evade immunological defences and establish a secure `niche´ within their hosts, 
pathogens employ several mechanisms of avoidance. Some avoid ingestion by the 
phagocytic cells designed to degrade them. Others promote their uptake and reside 
within `safe´ compartments inside host cells, protected from cellular mechanisms of 
microbial degradation. 
Classic endocytosis depends on clathrin coated pits and involves an intracellular 
pathway in which lysosomes fuse with internalised vesicles, degrading their contents 
(154). In contrast, and in clear benefit to pathogens, raft/caveolae-dependent 
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endocytosis does not feed into the lysosome pathway and does not result in the 
degradation of the cargo in the raft endocytic vesicles (128;154). If taken up by 
classic endocytosis, intracellular pathogens must avoid degradation in the 
endosome-lysosome pathway, either by escaping from endocytic vacuoles 
(phagosomes) into the cytoplasm before lysosomes fuse with phagosomes or by 
actively neutralizing microbicidal agents inside the phagolysosome after fusion 
(128;154). `Smart´ pathogens and bacterial toxins can avoid this problem by binding 
to caveolae/rafts and triggering endocytosis through a pathway that avoids 
lysosomes altogether. A wide range of pathogens (or their products) including 
viruses, parasites, bacteria and their toxins have been suggested to co-opt rafts for 
their benefit (refer to table1 and reviews (154;155;156). 
1.5.7.1 Lipid rafts in the internalisation of L. monocytogenes and other 
pathogens 
As mentioned above, a wide range of pathogens prefer raft-like ordered membrane 
domains for entry into the cell. For instance, E. coli strains that express FimH 
(bacterial adhesin) can gain entry and survive in phagoytic cells via CD48, a GPI-
anchored protein present in the rafts (91). Internalisation of Mycobacteria bovis has 
also been shown to be cholesterol dependent (92), suggesting an involvement of 
rafts in the uptake. Interestingly, the uptake of Plasmodium falciparum by 
erythrocytes, a cell type that is normally incapable of endocytosis /phagocytosis, 
seems to be mediated by rafts (155). 
Certain viruses also preferentially interact with rafts at sites for internalisation or for 
budding. Entry via rafts/caveolae has especially been shown for SV40. SV40 binds to 
MHC class I molecules and by an unknown mechanism leads, to the recruitment of 
caveolae around the virus whereby generation of a caveolae-like vesicle delivers the 
virus into the endoplasmic reticulum. It has also been proposed that the initial binding 
of HIV to CD4 promotes raft clustering (155). 
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Pathogens Receptors in rafts Function References 
Viruses    
HIV CD4, CXCR4, CCR5 Budding/viral fusion/trancytosis (156; 157) 
Ebola and Marbug viruses  Entry/Budding (158; 159) 
Measles virus  Assembly and budding (156; 159) 
simian virus 40 (SV40)  Caveolae-mediated entry (160) 
Influenza virus  Budding (161) 
Respiratory syncytial virus 
(RSV)  Replication (162; 163) 
Herpes simplex virus  Entry/Budding (164; 165) 
Epstein Barr virus  Signalling (156; 166) 
Echovirus 1  Entry (167) 
Echovirus 11  Entry/budding (168) 
Enterovirus 70 CD55/DAF Entry (169) 
Human T cell leukaemia virus 
type 1  Entry/Budding (170) 
Semliki-forest virus  Entry (171) 
Bacteria    
FimH-expressing E.coli CD48 Entry/signalling (154; 172) 
Shigella flexineri  CD44 Entry/Signalling  Cytoskeletal rearrangement (173) 
Campylobacter jejuni Cholesterol  Entry (156) 
Salmonella typhimurium EGF receptor Entry (155) 
Mycobacterium spp Cholesterol Entry/ intracellular survival (174; 175) 
Brucella spp. 
 
GM1, cholesterol, Scavenger 
receptor Entry/ intracellular survival (176; 177) 
Pseudomonas aeruginosa  Signalling (178) 
Legionella pneumophila  Entry (179) 
L. monocytogenes E-cadherin / HGF receptor Entry (180) 
Toxins    
Lipopolysaccharide  CD14 Signalling (181) 
E. coli Heat-labile enterotoxins GD1 Entry, signalling (182) 
Aeromonas hydrophila toxin  
(Aerolysin) GPI-anchored proteins Binding and oligomerization (183) 
Clostridium perfringens toxin 
 (Perfringolysin O) Cholesterol Oligomerization, signalling (184) 
L. monocytogenes toxin 
(Listeriolyisn O) Cholesterol Oligomerization, signalling (112;185) 
Eisenia foetida protein 
(Lysenin)  Sphingomyelin  (186) 
Vibrio cholera cytolysin Cholesterol Oligomerization (155) 
Cholera toxin  GM1 Binding, signalling (155) 
Helicobacter pylori toxin 
(VacA toxin)   GPI-anchored proteins Signalling (187) 
Parasites    
Toxoplasma gondii  Intracellular survival (188) 
Plasmodium falciparum  Entry (189) 
Theileria parva  Signalling (190) 
Table. 2. Pathogens and virulent factors that interact with host cells via rafts. 
 
There is also growing evidence to support the hypothesis that pathogenesis of prion 
disease is localized to caveolae-like domains. A region of the GPI-linked cellular 
prion protein targets it specifically to caveolae. This is an essential step in the 
conversion of the prion protein into the pathogenic form (93).  
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Recent studies by Cossart and co-workers suggest that L. monocytogenes the 
pathogen of interest in the present study also gains entry into nonphagocytic cells via 
rafts. Internalisation was found to be depended on membrane cholesterol and the 
presence of bacteria receptor E-cadherin in the DRM (180). Since the basolateral 
side of the epithelia (entry side of Listeria) is largely devoid of rafts associated 
molecules as described in section 1.5.5, the above findings are quite controversial. 
Furthermore, another study has reported that both the receptors for L. 
monocytogenes, c-met and E-cadherin predominantly reside in non-DRM fractions 
(191). Thus, the role of lipid rafts in the uptake of L. monocytogenes remains unclear.  
1.5.7.2 Rafts as concentration platforms for toxins 
Pore forming toxins utilize the concentration capacity of rafts not just for initial 
binding, but also rather for the subsequent oligomerization step which is a 
prerequisite for channel formation. This has been shown for aerolysin (Aeromonas 
hydrophila toxin) which specifically binds to GPI-anchored proteins and a variety of 
other pore forming toxins, including streptolysin O, perfingolysin O (PFO), lysenin, 
tetanus toxin, cholera toxin, Vibrio cholera cytolysin and Clostridium alpha toxin 
(155;183;184;192) (Table 1). 
1.5.7.3 Rafts as signalling complexes for pathogens 
While some pathogens exploit lipid rafts for entry, the high concentration of receptors 
and signalling molecules in these domains qualifies them as  ´detonation centres` for 
pathogens to initiate an inflammatory response by the host. For instance, 
engagement of CD48 by bacterial FimH triggers secretion of the pro-inflammatory 
cytokine tumor necrosis factor–α (TNF-α) (193). Lipopolysaccharide (LPS), a potent 
toxin produced by all Gram-negative bacteria, also interacts with rafts via the GPI 
anchored CD14 to trigger the MAP kinase pathway and cytokine production (155).  
This illustrates the importance of lipid rafts in cellular functions and how pathogens 
communicate with their target host cells via these membrane microdomains. 
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1.6 Pathogen Recognition by Toll-like receptors 
Toll receptor was originally identified in Drosophila as an essential receptor for the 
establishment of the dorso-ventral pattern in developing embryos (194). In 1996, 
Hoffmann and colleagues demonstrated that Toll-mutant flies were highly susceptible 
to fungal infection (195), a study that higlighted that the immune system, particularly 
the innate immune system, has a skillful means of detecting invasion by 
microorganisms. Subsequently, mammalian homologues of Toll receptor were 
identified one after another, and designated as Toll-like receptors (TLRs) (196). Over 
the last few years, it has become evident that members of the TLR family mainly 
transfer both the recognition and the subsequent response to pathogens. Eleven 
TLRs (TLR1-11) have been described so far (197-199).  
The cytoplasmic portion of TLRs shows high similarity to that of the interleukin (IL)-1 
receptor family, and is now called the Toll/IL-1 receptor (TIR) domain. Despite of this 
similarity, the extracellular portions of both types of receptors are structurally 
unrelated. The IL-1 receptors possess an Ig-like domain, whereas TLRs bear leucine-
rich repeats (LRRs) in the extracellular domain. Each TLR has been shown to 
recognise specific pathogen-associated molecular patterns (PAMPs) (200), i.e 
conserved microbial patterns shared by large groups of pathogens, but not found in 
higher eukaryotes except under pathological conditions such as stress (197-199). Of 
the eleven TLRs described so far, TLR2 and TLR4 are the most relevant in the 
present studies and the best-investigated family members. TLR4, the 
Lipopolysacharide (LPS) receptor, is important for the recognition of Gram-negative 
bacteria, whereas TLR2 has been designated the major receptor for Gram-positive 
bacteria by virtue of its capacity to recognize major cell wall constituents of Gram-
positive microorganisms, such as peptidoglycan (PGN), lipoteichoic acid (LTA), and 
lipoproteins (197-199). TLR2 homodimers or, TLR1/TLR2 and TLR2/TLR6 
heterodimers, have been demonstrated to migrate to phagosomes within phagocytic 
cells, where they might sample the contents and signal the presence of an invader 
(201;202). Heterodimerization of TLR2 with other TLRs like TLR6 or TLR1 is required 
to activate TNF-α production in macrophages (202). Moreover, evidence exists that 
TLR2 is directly involved in bacterial killing by monocytes and macrophages (203). 
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Figure 1.4. Toll like receptors and their ligands. Bacteria are sensed by five Toll-like receptors 
(TLRs) in humans: lipopolysaccharide (LPS) is the main bacterial ligand for TLR4; lipotechoic acid and 
diacylated lipopeptides are sensed by a TLR2–TLR6 dimer; triacylated lipopeptides are sensed by a 
TLR2–TLR1 dimer; CpG motifs are sensed by TLR9; and flagellin is sensed by TLR5. In mice, an 
additional TLR, TLR11, is also involved in anti-bacterial responses and senses uropathogenic 
bacteria. For anti-fungal responses, a TLR2–TLR6 dimer senses zymosan. Five TLRs are involved in 
anti-viral responses: TLR4 senses F protein from respiratory syncytial virus (RSV); double-stranded 
RNA (polyI:C) is sensed by TLR3; TLR9 senses viral CpG DNA (not shown); and TLR7 (human only) 
and TLR8 (human and mouse) sense single-stranded viral RNA (ssRNA). Protozoal products such as 
glycosylphosphatidylinositol (GPI)-anchor proteins are also sensed by TLR2. Finally, products of 
inflamed tissues such as heat-shock protein 60 (HSP60) are sensed by TLR4. This repertoire means 
that almost all pathogens that infect humans will be sensed by TLRs. GIPL, glycoinositolphospholipid; 
VSV, vesicular stomatitis virus (Illustration from Nature Reviews Immunology (198). 
1.6.1 Signalling via TLRs 
The activation of TLR signalling pathways originates from the cytoplasmic TIR 
domains. This involves a proline residue in the TIR domain that is conserved among 
all TLRs, except for TLR3, and its substitution to histidine caused a dominant 
negative effect on TLR-mediated signalling (201;204;205). In the signalling pathway 
downstream of the TIR domain, a TIR domain-containing adaptor, MyD88, was first 
characterized to play a crucial role. In addition, recent accumulating evidence 
indicates that TLR signalling pathways consist, at least, of a MyD88-dependent 
pathway that is common to all TLRs, and a MyD88-independent pathway that is 
peculiar to the TLR3 and TLR4 signalling pathways (206). Analysis of the MyD88-
independent pathway led to the identification of two adaptors; TIRAP (TIR domain-
containing adaptor protein) and TRIF (TIR domain-containing adaptor inducing IFN-
β). These two adaptors regulate the TLR-mediated signalling pathways by providing 
specificity for individual TLR signalling cascades (207;208;197;209). Signal 
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transduction processes activated by Toll-like receptors (TLRs) include the important 
transcription factor NF-κB and 2 MAP kinases, p38 and Jun N-terminal kinase. These 
signals ultimately give rise to increased expression of a multitude of pro-inflammatory 
proteins (197;210). TLRs are expressed constitutively or inducibly on a variety of 
cells such as monocytes / macrophages, dendritic cells (DCs), B cells, T cells, mast 
cells, and endothelial cells but the pattern of expression of individual TLRs differs for 
specific cell types (211). 
 
 
Figure 1.5. TLR-mediated pathways. MyD88 binds to the cytoplasmic portion of TLRs through 
interaction between individual TIR domains. Upon stimulation, IRAK-4, IRAK-1, and TRAF6 are 
recruited to the receptor, which induces association of IRAK-1 and MyD88 via the death domains. 
IRAK-4 then phosphorylates IRAK-1. Phosphorylated IRAK-1, together with TRAF6, dissociates from 
the receptor and then TRAF6 interacts with downstream kinases such as TBK1 that phosphorylates 
the IKK complex, consisting of IKKα, IKKβ, and NEMO/IKKγ thereby induces the activation of the 
transcription factors NF-κB that leads to the induction of inflammatory cytokines. TIRAP is a second 
adaptor that specifically mediates the MyD88-dependent pathway via TLR2 and TLR4. In the TLR4- 
and TLR3-mediated signaling pathways, a MyD88-independent pathway exists mediated by TRIF that 
leads to activation of IRF-3 and IFNβ via TBK1 and IKKε/IKKi. (Illustration from (197). 
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1.6.2 Role of TLRs in signal induction by L. monocytogenes 
There is ample evidence to suggest that L. monocytogenes interacts with several 
TLRs. As mentioned above, TLR2 recognizes Gram-positive bacterial compounds 
such as peptidoglycan, Lipotechoic acid and lipoproteins (198). That TLR2 is a 
signalling receptor for L. monocytogenes products was revealed based on in vitro 
studies carried out on Chinese hamster ovary cells transfected with TLR2 or cells 
from TLR2 deficient mice (212;213). So far, the strongest evidence for the 
significance of TLR signalling by L. monocytogenes in vivo comes from infection 
studies done on mice deficient in MyD88 the common adaptor protein of TLR 
signalling. MyD88-/- mice are highly susceptible to Listeria infection and demonstrate 
diminished capacity to secrete cytokines, NO release, as well the cell surface 
expression of costimulatory molecules in response to Listeria infection (213;214). 
Although there is a general consensus on the role of TLR2 in signal induction by L. 
monocytogenes products, its in vivo relevance is still controversial. Infection 
experiments by Edelson and Unanue found that although TLR signalling is required 
for NO and cytokine production by macrophages, resistance to Listeria infection 
between the TLR2-/- and wild-type mice was equivalent (213). This is however in 
contrast to the more recent study in which TLR2-/- mice were shown to be 
significantly susceptible to Listeria infection (214). The discrepancy between these 
two studies could be due to the differences in experimental conditions such as the 
route of infection as well as the Listeria strain used. Notwithstanding above reasons, 
there is a growing appreciation that L. monocytogenes does also trigger signalling via 
other TLRs, thus causing some redundancy in TLR recognition. In principle, TLRs 1, 
2, 4, 5, 6 and 9 may be involved in the in vivo response to live Listeria through 
recognition of lipoprotein (heterodimer of TLRs 1 and 2) (198;199;215), 
peptidoglycan (heterodimer of TLR2 and TLR6) (202;216), lipotechoic acid (TLR4 
(216), Listeria flagellin (TLR5) (198;217). Bacteria DNA (199;218).  
The signals triggered by LLO could also contribute to redundancy in TLR signalling 
by L. monocytogenes. NF-κB is the key transcription factor through which TLR 
signalling activates proinflammatory genes. As shown below, NF-κB is also one of 
the major transcription factors activated by LLO thus indicating a convergence 
between the TLRs and LLO activated signalling pathways. A recent studies has 
reported that LLO and other cholesterol dependent cytolysins induce inflammatory 
response in host cells in a TLR4 dependent manner (219;220). How and at what 
1. Introduction  31 
level the LLO and TLR signals converge are unresolved questions which could help 
to shade more light into this redundancy in the signals induced in the host by L. 
monocytoges and other Gram-postive bateria that express cholesterol dependent 
cytolysins. 
1.7 Objectives of the work 
The overall aim of this work is to elucidate the mechanisms of signal induction by 
Listeriolysin O, the major virulence factor of L.monocytogenes, in order to understand 
how such signals influence the course of listeriosis.  
As outlined in the introduction, LLO triggers signals in host cells via pore and non-
pore dependent mechanisms. One of the pore dependent mechanisms of signal 
transduction by LLO is Ca2+ flux induction. So far, Ca2+ signal induction by LLO has 
largely been deduced based on studies carried out using bacterial preparations 
(72;80). Since Ca2+ signals can be induced by other components such as PI-PLC, no 
conclusive studies have so far been carried out to specifically delineate the precise 
mechanisms of Ca2+ induction by LLO.  
• The first objective of study was to dissect the mechanism of Ca2+ signalling by 
LLO. In particular, whether LLO also triggers Ca2+ release from intracellular 
stores in addition to Ca2+ influx, and the underlying mechanisms have been 
investigated. For that, recombinant LLO purified from the non-pathogenic 
Listeria innocua strain, which does not express PI-PLC - a potential 
contaminant that could complicate interpretation of Ca2+ signals induced by 
LLO, was used.  
• The second objective was to delineate the pore independent mechanisms of 
signal induction by LLO. Since LLO is a cholesterol dependent cytolysin and 
cholesterol is the mains structural component of lipid rafts, whether LLO 
signals via lipid rafts and the underlying mechanisms have been investigated. 
• The third objective was to investigate the functional outcome of signal 
induction in host cells by LLO, and how such signals shape the course of 
listeriosis. The studies in this part were largely focused on the cellular 
responses triggered by LLO in mast cells both in vitro as well as in vivo.  
• In addition to LLO, several other bacterial components also contribute to the 
overall host responses triggered by L. monocytogenes. One of the prominent 
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signaling pathways activated by bacterial pathogens are those via Toll like 
receptors (TLRs). As such, TLR deficient animals were analysed with the aim 
of understanding whether and how the LLO induced signals synergizes with 
those activated via the TLRs to shape host`s response during Listeria 
infection. 
Taken together, it was considered if carried out, these studies would yield important 
information that would further the understanding of how L. monocytogenes interacts 
with the host. 
 2 Materials and methods 
2.1 Animals 
Female BALB/c mice were purchased from Harlan (Borchen, Germany) and used at 
an age of 10-12 weeks. C57BL/6 mice and MyD88-/-, TLR2-/-, TLR4-/-, and TLR2/4-/- 
mice were a gift from Dr. Uwe Klemm (Max Planck Institute for Infection Biology, 
Berlin, Germany). 
2.2 Antibodies and reagents 
Mouse anti-HA antibodies (HISS-Diagnostics, Freeburg, Germany), CT-B and 
polyclinic goat anti CT-B (Caliches, Darmstadt, Germany). Cy3-streptavidin and 
peroxidase-goat anti-rabbit (Jackson Immunoresearch Laboratories, Hamburg, 
Germany), FITC-rat monoclonals anti-mouse CD14 (mrC5-3), rat anti-mouse 
transferrin receptor (TFR), streptavidin-FITC (BD Pharmingen, Heidelberg, 
Germany). Goat anti-rat and goat-anti rabbit antibodies coupled to alexa488 were 
obtained from Molecular probes, mouse anti-phosphotyrosine (PY99), rabbit anti-Lyn 
and rabbit anti-Syk were obtained from Santa Cruz Biotechnology. Rabbit anti-
phosphotyrosine (Chemicon International Temecula CA USA), anti-rabbit IgG-FITC 
(Sigma Immunochemicals, Deisenhofen, Germany), filipin (Sigma-Aldrich Chemicals, 
Steinheim, Germany) were obtained from the indicated venders. Cy2-donkey anti-
goat Ig was a kind gift from Dr. D. Monner (GBF, Braunschweig, Germany). Wild type 
LLO and HA-LLO were purified from Wisteria innocuous hyper-expressing strains 
(221). p-nitro phenyl-N-acetyl-β-D-glucosaminide and tharpsigargin were obtained 
from Sigma; while Indo-1-AM, BAPTA-AM and ER-tracker, were from Molecular 
Probes. Dulbecco's modified Eagle's medium (DMEM) and Calcium free DMEM were 
from Gibco. 
2.3 Cell lines and primary cells 
J774 cells were from our cell line collection. Rat basophilic leukemia cell line (RBL-
2H3) was kindly provided by Prof. Pecht I (The Weizmann Institute of Science, 
Israel). Bone marrow derived mast cells (BMMC) were generated as follows: Bone 
marrow cells were harvested by repeatedly flushing femurs and tibias with Iscove's 
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modified Dulbecco's medium supplemented with 10% fetal calf serum (FCS; 
inactivated at 56°C), 2 mM L-glutamine, 1 mM pyruvate, 100 U of penicillin/ml, 100 µg 
of streptomycin/ml, 20 U of mIL-3/ml (IMDM).  The cell culture was established at a 
density of 2 x106 cells/ml in IMDM. Nonadherent cells were transferred every 2 to 3 
days in to fresh plates with 20% of their accustomed medium. After 4 weeks of 
culture, more than 99% of cells were identifiable as mast cells as determined by 
toluidine blue staining and flow cytometric analysis of cell surface expression of c-kit 
and FcεRI. 
2.4 Depletion of neutrophils and mast cells in mice  
Except for minor changes depletion of neutrophils or mast cells was done according 
the published protocols (222) and (223) respectively. Briefly, to deplete BALB/c mice 
of their mast cells, mice were given an intraperitoneal injection of 1.5 mg of anti-c-Kit 
monoclonal antibody (ACK2) the day before each challenge with L. monocytogenes. 
On the other hand, depletion of neutrophils in mice was accomplished by injecting 
them intraperitoneally with 100 µg of the RB6-8C5 MAb. Control mice were injected 
intraperitoneally with equivalent amounts of rat immunoglobulin G instead of the 
ACK2 or RB6-8C5 antibodies. 
2.5 Ca2+ flux measurements by flow cytometry 
5 x 106 BMMCs in 500 µl DMEM were incubated with 50 µM INDO 1-AM for 45 min 
at 37°. Cells were then washed three times in 5 ml Ca2+ free DMEM. In the last 
washing steps the cells were partitioned into two, and the aliquots washed and 
resuspended in either normal or Ca2+ free medium. Cells kept on ice until ready for 
calcium measurement were warmed up to 37°C and the cytosolic Ca2+ was 
determined for the first 30 sec and then continued after addition of the stimulus. For 
the FcεRI cross-linking, INDO 1-AM labelled cells were incubated with an anti-BSA-
DNP Age (5 µg/ml) for 30 min on ice then washed. The FcεRI was cross-linked by 
adding BSA-DNP (10 µg/ml). Measurements were carried out on a MoFlo high-speed 
cell sorter (DakoCytomation USA) equipped with an UV argon ion laser (351-363 
nm). INDO-1 emissions were detected with 405/30 (Ca-bound INDO-1) and 515/30 
(Ca-free INDO-1) fluorescence filters, and the ratio of bound / free was recorded. 
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Data were analysed by FloJo software (Tree Star, San Carlos, USA). Data were 
normalized for the fluctuations in the starting measurements by the Excel software. 
2.6 Measurement of β-Hexosaminidase activity 
Release of β-hexosaminidase was measured as an index of mast cell degranulation 
using a standard method (224). In brief, 2 x 105 BMMCs in 200 µl IMDM were seeded 
into each well of a 96 well plate then stimulated with either LLO/CL-LLO (0.25 µg/ml) 
or infected with L. monocytogenes (MOI 100). After incubation at 37°C for 2 hours, 
the supernatants were transferred to a 96-well plate. The rest of the supernatants 
were removed, and cells were lysed in 0.5% Triton X-100 solution. To determine the 
β-hexosaminidase content of supernatants and cells 50 µl of samples were incubated 
with 50 µl of 1 mM p-nitrophenyl-N-acetyl-β-D-glucosaminide (Sigma) dissolved in 
0.1 mM citrate buffer, pH 5.0, in a 96-well microtitre plate for 1h at 37°C. The reaction 
was stopped by adding 150 µl of 0.1 M carbonate buffer, pH 10.5. Optical density 
was measured at 405 nm in a microplate reader (BIO-RAD), and the net percentage 
of the β-hexosaminidase released was calculated as follows: β-hexosaminidase in 
supernatant/ (β-hexosaminidase in supernatant +  β-hexosaminidase in cells) x 100. 
2.7 Infection of mast cells with L. monocytogenes 
After incubating with L. monocytogenes at a multiplicity of infection (MOI) of 100 for 1 
hour, the BMMCs were washed then incubated for additional 3-4 hours in the 
presence of 10 µg/ml gentamycin. Thereafter, the cell pellet and the culture 
supernatants were collected for RT-PCR analysis and TNF bioassay, respectively. 
2.8 TNF Bioassay  
Following stimulation of BMMC with LLO or infection with L. monocytogenes, the 
biological activity of TNF in the supernatants was assayed using the TNF-sensitive 
murine fibroblasts L929. Briefly: 4x104 cells were seeded into each well of a 96-well 
plate. After overnight incubation, the medium was replaced with 100 µl of medium 
containing actinomycin D (6.25 µg/ml) and 50 µl of the sample supernatant was 
added. Serial dilutions of recombinant TNF-α  were also used as reference. After 
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incubating the plate for 24 h the supernatants were aspirated and cell viability 
determined using the EZ4U KIT (BIOMEDICA, Viena, Austria) according to the 
manufacturer’s instructions. The TNF concentration was determined by comparing 
the L929 killing induced by the samples with killing induced by dilutions of TNF-α of 
know concentrations. 
2.9 RT- PCR analysis 
mRNA was isolated from BMMCs using the RNAEasy Mini Kit from Qiagen and 
reverse transcribed into cDNA using the SuperScript II RNAseH Reverse 
Transcriptase kit from Invitrogen. PCRs were performed with primers: ( 5`-3`) TNF-α: 
(TCT CAT CAG TTC TAT GGC CC; GGG AGT AGA CAA GGT ACA), MCP-1: 
(GCCCCACTC ACCTG CTGCTA; TTTACGGGTCAACTTCACATTCAA), MIP-1α: 
(CTGCCCTTGCTGTTCTTCTCTGTA; GATCTGCCGGTTTCTCTTAGTCA) and the 
house keeping gene RPS9: (CTG GAC GAG GGC AAG ATG AAG C; TGA CGT 
TGG CGG ATG AGC ACA). Amplification conditions were: denaturation at 94°C for 
1min followed by 27 and 32 cycles (for RPS9 and TNF-α respectively of repeated 
denaturation (20s at 94°C), annealing (20s at 58°C) and extension (20s at 72°C). 
PCR products were analyzed on a 2 % agarose gel. 
2.10 Neutralization of LLO with antibody and cholesterol 
To make the LLO+M344 complex, 10 µg of LLO was incubated with 0.5 mg of the 
M344 antibody in a 100 µl PBS (i.e. 0.1 mg/ml LLO in 5 mg/ml of antibody solution) 
for 45 min at room temperature. To make CL-LLO+M344, 5 µl of cholesterol stock (4 
mg/ml in chloroform) was added to 95 µl of the LLO+M344 solution then vortexed 
thoroughly.  
To treat cells, 5ul of either the LLO+M344 or CL-LLO+M344 solutions was added to 
cells on cover slips immersed in 500 µl of tissue culture medium. This brings the final 
concentration of LLO to 1 µg/ml while that of cholesterol to 2 µg/ml. After 10 min 
incubation the cells were washed, fixed then stained. Cells treated with this 
concentration of cholesterol alone showed no visible difference with the untreated. 
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2.11 Preparation of Detergent Resistant Membranes 
(DRMs) 
Monolayers of J774 cells (about 107 cells /200 ml tissue culture flask) were incubated 
with 2 µg/ml LLO or CL-LLO for 15 min at room temperature (RT). Subsequently cells 
were scrapped off the flasks, washed in ice cold PBS, then lysed at 4°C in 1 ml 1 % 
Triton X-100 buffer (5 mM EDTA, 25 mM Tris pH 7.5, 0.15 M NaCl, 1% Triton X-100 
plus a cocktail of protease inhibitors (Roche Diagnostics Mannheim, Germany). 
Lysates were adjusted to 40% sucrose by adding 1 ml of 80% sucrose in 1% Triton 
X-100 buffer before over layering with 11 ml of 35% sucrose, then 4 ml of 16% 
sucrose. After centrifugation at 150,000 x g for 24 h at 4°C in a SW 28.1 rotor 
(Beckman Instruments, München, Germany), 12 equal fractions collected from top to 
bottom were precipitated in 10% Trichloroacetic acid (TCA). After estimating the 
protein concentration in each fraction, equal amounts were loaded on the gels and 
analysed by immunoblotting for LLO, CD14, CD16, CD24 and TFR. 
2.12 Separation of monomeric and oligomeric LLO 
Separation of monomeric and polymeric LLO from J774 cells was carried out as 
previously described (66;225). Briefly: 5x106 cells in 100 µl PBS were incubated with 
LLO at a concentration of 10 µg/ml for 15 min at RT. After lysis in 1 ml of 250 mM 
DOC (250 mM deoxycholate, 20 mM Tris HCl, 1 mM EDTA pH 8.0), the cell lysates 
were applied to a continuous 10-50% sucrose gradient (17 ml) containing 6.25 mM 
deoxycholate, 20 mM Tris-HCl, 1 mM EDTA pH 8.0 then centrifuged for 3 h at 150 
000 x g using a SW 28.1 rotor at 4 °C. 11 equal fractions were collected from top and 
precipitated in 10% TCA then analysed for LLO by immunoblotting. Purified LLO and 
CL-LLO were fractionated and analysed in parallel. 
2.13 Immunofluorescence staining and microscopy of 
J774 cells 
Two procedures were used for fixation; incubation in 4% paraformaldehyde for 15 
min at room temperature (PFA fixation) or PFA fixation followed by 10 min incubation 
in a 1:1 acetone/methanol mixture at -20°C (PFA/Ac-MeOH fixation). 
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J774 cells grown on cover slips were incubated with HA-LLO (1 µg/ml in incomplete 
IMDM) for 10 min at room temperature (RT), washed, then fixed. Alternatively, cells 
were first fixed before incubation with HA-LLO. Cell surface GM1, was labeled with 
10 nM CT-B for 40 min at RT after fixation. 
Before incubation with antibodies, the fixed cells were blocked in 0.5% BSA/PBS for 
30 min (RT). HA-LLO was revealed using a mouse anti-HA (1:2000) or a biotin-
coupled anti-HA (1:4,000) followed by a goat anti mouse-Cy3 (1:2,000) or Cy3-
streptavidin (1:5000) respectively. CT-B was stained using a polyclonal goat anti-CT-
B followed by Cy2-donkey anti-goat Ig. For double staining of HA-LLO and CD14 
(1:50), cells treated with HA-LLO or CL-HA-LLO were fixed in PFA or PFA/Ac-MeOH, 
before incubation for 1 h on ice with either (1) mouse anti-HA-biotin antibody followed 
by Cy3-streptavidin and FITC-rat anti-CD14 or (2) a mixture of mouse anti-HA 
(1:2,000) and rat anti-CD14 followed by a mixture of Cy3-goat anti-rat(1:2,000) and 
alexa488 coupled goat anti-rat (1:100). The TRF was stained using a rat anti-TFR 
followed by alexa488 coupled anti-rat (1:100). HA-LLO and CD16 on PFA/Ac-MeOH 
fixed cells was revealed using anti-HA and rat anti-CD16 followed by Cy3- anti-
mouse and alexa488-anti-rat. 
For the co-clustering of HA-LLO and Lyn, J774 cells treated with 1 µg/ml HA-LLO 
were fixed by PFA/Ac-MeOH before staining with anti-HA and rabbit anti-Lyn (1:100) 
followed by Cy3-anti-mouse and alexa488 coupled goat anti-rabbit antibodies. For 
the HA-LLO and tyrosine phosphorylation experiments, J774 cells were cultured for 
24 hrs in incomplete medium before incubation with HA-LLO (0.25 µg/ml) for 5 min at 
37°C. After fixation, cells were stained for HA-LLO as described above then 
permeabilized using 0.1% Triton X-100 /PBS for 1 min. Subsequently, cells were 
blocked with 3% BSA/PBS for 30 min (RT), then stained for phosphotyrosines using 
a rabbit anti-phosphotyrosine antibody followed by a FITC-goat anti rabbit Ig. 
Cover slips were mounted onto slides using Flouprep mounting medium (bioMérieux, 
Marcy l´Etoile, France) then examined using an Axiovert 135 TV microscope (Zeiss, 
Oberkochen, Germany) equipped with Cy3, FITC filters and a Plan-Apochromat 
100X/1.40 NA oil immersion objective. Images were recorded with a cooled (-25°C), 
back-illuminated CCD camera. 
Images were processed using VayTek Microtome digital deconvolution (Fairfiel IA 
USA) and Adope Photoshop softwares (Adope Systems, Inc., Mountain View, CA 
USA) on a Macintosh computer (Apple Computer Co., Cupertino CA USA). 
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For quantitative colocalization, fluorescent images were captured by scanning laser 
confocal microscopy using a Plan Apo lens (40 x, NA 1.4, oil immersion) and 
analysed with Zeiss LSM 510 software (Carl Zeiss, Jena, Germany). 
2.14 Mast cells staining and microscopy 
BMMCs untreated or treated with LLO (0.25 µg/ml) or ionomycin (1 µM) for 45 min, 
were pelleted, then fixed and permeabilized by incubation in a 50:50 
Acetone/methanol fixative for 10 min at –20°C. Cells were blocked in 3% BSA for 30 
min then stained with a mouse anti-NFATc1 (Santa Cruz Biotechnol. CA) for 45 min 
at RT. After washing, the cells were incubated with a Cy3-Goat anti-mouse antibody 
for 45 min. Cells were again washed, transferred onto slides by cytospining and 
cover slips were mounted onto them using Fluoprep mounting medium. 
For the time series movies, RBL-2H3 mast cells grown on cover chamber slides were 
labelled with 2 µM BODIPY ER-tracker in phenol red free medium for 30 min at 37°C. 
After washing, fluorescent images of the cells were captured at 37°C at an interval of 
30 sec by scanning laser confocal microscopy using a Plan Apo lens (40x, NA 1.4, oil 
immersion). The time series of the images was converted into an avi movie using the 
Zeiss LSM 510 software (Carl Zeiss, Jena, Germany). 
2.15 Immunoprecipitation and western blot analysis 
J774 cells grown for 24 hrs in incomplete IMDM medium to confluency (107 cells/ 200 
ml culture flask) were stimulated with 0.25 µg/ml HA-LLO at 37°C. After 2 and 4 min, 
cells were scrapped off, washed in ice cold PBS and lysed in 600 µl 1% Triton-X 100 
extraction buffer (described above) supplemented with 2 mM Na3VO4, 10 mM NaF 
and a cocktail of protease inhibitors. After 15 min on ice, the soluble and insoluble 
materials were separated by centrifugation at 20,000g for 30 min. The pellet 
containing the insoluble materials (designated as DRM) was washed 3x with 1% 
Triton-X 100 extraction buffer and then solubilized on ice for 30 min in 600 µl of RIPA 
buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP40, 2 mM Na3VO4 
and 10 mM NaF containing a cocktail of protease inhibitors).  
For immunoprecipitation 500 µl of each of the fractions was filled up to 1 ml and then 
incubated at 4°C with 1µg of the anti-phsophotyrosine antibody (PY99). After 2 hours 
20 µl of ProteinA/G-Agarose was added and the lysates incubated overnight at 4°C. 
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The Agarose pellet were washed 3 times in RIPA buffer then boiled in SDS sample 
buffer and subjected to SDS-PAGE and immunoblotting using rabbit anti-Lyn and 
rabbit anti-Syk as developing reagents. Sample aliquots of pre-immunoprecipitation 
lysates were also analyzed for phosphotyrosines, Lyn and Syk. 
 3 Results 
Signal induction in host cells is an essential prerequisite for the survival of pathogens 
in the host. Thus many of the virulence factors of pathogens are devoted to such 
activity. Listeriolysisn O (LLO) is a paradigm of such virulence factors that is not only 
essential for the escape of the bacterium into the cytosol but more importantly 
induces many cellular responses in the target cells of L. monocytogenes. The goal of 
the present study was to shed some light into the mechanisms that underlie signal 
induction by LLO. The results presented below are in three parts. The first part 
(section 3.1) deals with the mechanisms of calcium induction by LLO while the 
second part (section 3.2) covers the role of lipid rafts in the induction of signalling by 
LLO. The third part (section 3.3) deals with the functional outcome of signal induction 
by LLO in mast cells and their significance in vivo during Listeria infection. The fourth 
part (section 3.4), deals with how the signals triggered by LLO synergize/overlap with 
those triggered by other listerial components that engage TLRs and how this 
determines the overall host response to Listeria organism. 
3.1 Induction of calcium signals in host cells by LLO 
As discussed above, induction of calcium signals in host cells has emerged to be a 
common feature employed by various bacterial pathogens to communicate with their 
target host cells. Previous studies have shown that L. monocytogenes induce calcium 
signals in host cells in an LLO dependent manner (71;80;88). The present studies 
were carried out with the aim of delineating the mechanism underlying calcium signal 
inducton by LLO. 
3.1.1 LLO induces release of Ca2+ from intracellular stores in mast 
cells 
Mast cells have been studied mainly in relation to allergic diseases. However, the 
importance of these cells in the control of pathogens is now well recognised (226). 
Mast cells are endowed with at least two important properties which are instrumental 
in the host defence: (i) their strategic location at the host-environment interfaces 
which are the ports of entry for pathogens; (ii) in response to the appropriate stimuli, 
mast cells rapidly secrete preformed pro-inflammatory mediators stored in granules. 
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They are also able to quickly synthesize such mediators upon stimulation. Since 
degranulation and synthesis of pro-inflammatory mediators by mast cells can be 
regulated by Ca2+ signals, mast cells were considered an ideal cell type to conduct 
functional and mechanistic studies on the induction of Ca2+ fluxes by LLO.  
To investigate the mechanism of Ca2+ signals by LLO, bone marrow derived mast 
cells (BMMCs) were stimulated with the toxin in normal or Ca2+ free medium and 
Ca2+ flux was analysed by flow cytometry. LLO was found to elevate cytosolic Ca2+ in 
mast cells both in the presence and absence of extracellular Ca2+ (Figure 3.1A). Ca2+ 
elevation in Ca2+ free medium was lower indicating that in normal medium, the 
magnitude of Ca2+ elevation by LLO is a product of influx of extracellular Ca2+ and 
release from intracellular Ca2+ stores. The calcium ionophore ionomycin also 
triggered Ca2+ elevation in normal as well as in Ca2+ free medium. Compared to LLO 
however, Ca2+ induction by ionomycin was almost immediate (Figure 3.1A). The 
delayed kinetic of Ca2+ induction by LLO probably illustrates the critical time frame 
required for the transformation of LLO monomers into functional pores. 
 
 
Figure 3.1. LLO induces influx of Ca2+ as well as release from intracellular stores. (A) Indo 1-AM 
loaded BMMCs were stimulated with LLO or ionomycin in normal or Ca2+-free medium. (B) BMMCs 
were incubated with BAPT-AM for 37°C for 30 min to chelate intracellular Ca2+. After washing, cells 
were loaded with Indo 1-AM before stimulation with LLO in normal or Ca2+-free medium. A 30 sec 
baseline was recorded each time before stimulation. The arrows indicate the time points of stimulation. 
Preincubation of LLO with cholesterol abrogates its ability to form pores but not its 
membrane binding (66;112;185). When tested, cholesterol inactivated LLO (CL-LLO) 
was found not to induce any Ca2+ flux in the BMMCs (Figure 3.1A). This suggests 
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that in such cells, the influx and release of Ca2+ from intracellular stores occurs 
exclusively via pore dependent mechanisms. To confirm the release of Ca2+ from 
intracellular stores, cells were also stimulated with LLO after the chelation of 
intracellular Ca2+ using BAPTA-AM. A diminished Ca2+ response was obtained in 
BAPTA-AM pretreated cells, again emphasizing the contribution of the intracellularly 
stored Ca2+ to the overall Ca2+ response triggered by LLO (Figure 3.1B). 
3.1.2 LLO and L. monocytogenes induce de novo synthesis and 
secretion of proinflammatory factors by mast cells 
To evaluate the functional outcome of LLO induced Ca2+ fluxes, BMMCs were 
analysed for degranulation by measuring the secretion of hexosaminidase, an 
enzyme that is stored in the granules of mast cells and released upon degranulation. 
Both LLO and L. monocytogenes were found to induce release of hexosaminidase 
(Figure 3.2A). Consistent with the data on Ca2+ induction (Figure 3.1A), mast cell 
degranulation by LLO and L. monocytogenes was found to be lower in Ca2+ free 
medium while no degranulation was induced by CL-LLO (Figure 3.2A). 
Tumor necrosis factor-alpha (TNF-α) is one of the preformed cytokines rapidly 
secreted by the mast cells via degranulation (226). Independent of that, mast cells 
also synthesize TNF-α in response to the appropriate stimuli. Therefore, whether 
LLO and L. monocytogenes activate TNF-α gene transcription was also tested. 
Analysis by RT-PCR demonstrated that both LLO and L. monocytogenes upregulate 
TNF-α mRNA with a peak response at 3-4 h post stimulation (Figure 3.2B). The 
higher level of specific mRNA elicited by bacteria indicates that, in addition to LLO, 
other virulence factors also contribute to this response. The accumulating TNF 
activity in culture supernatants of the corresponding samples revealed that the 
specific TNF-α mRNA is indeed translated and TNF-α is secreted following 
stimulation by LLO and L. monocytogenes (Figure 3.2C). 
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3.1.3 The TNF-α gene transcriptional activation by LLO is pore 
dependent, occurs via NFAT activation, and occurs 
independently of extracellular Ca2+ 
What is the significance of Ca2+ signalling on the TNF-α gene transcriptional 
activation by LLO? When BMMCs were stimulated in normal or Ca2+ free medium, 
LLO was found to induce upregulation of TNF-α mRNA in both cases while CL-LLO, 
which does not induce Ca2+ signals, elicited either a minor or no response (Figure 
3.3A). This suggests that induction of Ca2+ signals by LLO plays a major role in the 
activation of the TNF-α gene. The Nuclear Factor of Activated T cells (NFAT), a 
calcium dependent family of transcription factors, is involved in the regulation of the 
transcription of a broad range of cytokines and chemokines. 
 
 
Figure 3.2. LLO and L. monocytogenes induce de novo synthesis and secretion of pro-
inflammatory factors in mast cells (A) Degranulation was analysed in untreated BMMCs or 
following incubation with LLO or cholesterol inactivated LLO (CL-LLO) or L monocytogenes. β-
hexosaminidase activity in the culture supernatants was measured as an indictor of degranulation. 
BMMCs were either treated with LLO, or infected with L. monocytogenes, and at the indicated time 
points, the cell pellets were collected and analyzed by RT-PCR for TNF-α mRNA (B). The mRNA of 
the house-keeping gene RPS9 was used as an internal control for the amount of cDNA used. For the 
secreted TNF-α, culture supernatants of the cells in (B), were collected and tested in a bioassay (C).  
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To determine whether LLO activates transcription of the TNF-α gene via NFAT, first, 
whether or not LLO activates the translocation of NFAT to the nucleus, was tested.  
 
 
Figure 3.3. The TNF-α gene transcriptional activation by LLO is pore dependent, occurs via 
NFAT activation, and occurs independently of extracellular Ca2+. (A) BMMCs were analyzed for 
TNF-α mRNA upregulation by RT-PCR following a 4 h stimulation with LLO or in normal or Ca2+ free 
medium. (B) BMMCs were left untreated or stimulated with ionomycin or LLO for 45 min at 37°C in 
normal or Ca2+ free medium. Permeabilized cells were then stained with an anti-NFATc1 antibody. The 
arrowheads indicate NFATc1 accumulated in the nuclei. (C) BMMCs were left untreated (Ctrl) or 
stimulated with LLO or ionomycin for 4 h in Ca2+ free medium in the presence/absence of 1 µM 
Cyclosporine A (CSA). Samples were analyzed for TNF-α mRNA upregulation by RT-PCR. 
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NFATc1 nuclear translocation was induced by LLO in normal as well as Ca2+ free 
medium (Figure 3.3B), indicating that Ca2+ released from the intracellular stores by 
LLO alone is sufficient to activate nuclear translocation of the NFAT family of 
transcription factors. 
To explicitly demonstrate the role of NFAT in the induction of TNF-α gene 
transcription by LLO, BMMCs were stimulated with LLO in the presence of 
cyclosporine A (CSA), a potent inhibitor of NFAT activation. As shown in Figure 3.3C, 
blocking NFAT activation using CSA inhibited the upregulation of TNF-α mRNA by 
LLO. Taken together, these results show that: (i) LLO activates TNF-α expression via 
the calcium dependent family of transcription factors NFAT; and (ii) the Ca2+ released 
from intracellular stores by LLO alone is sufficient to trigger this response. 
3.1.4 LLO penetrates the ER to cause release of ER components 
Thus far, the data presented show that irrespective of Ca2+ influx, Ca2+release from 
intracellular stores by LLO is sufficient to trigger cellular responses and that the lack 
of Ca2+ signals by CL-LLO suggests that the release from intracellular stores occurs 
via a pore dependent mechanisms. What then is the mechanism of Ca2+ release from 
the intracellular stores? As pointed out earlier, the large pores formed by CDCs allow 
the delivery of macromolecules as large as 400 kDa molecular mass into the cytosol 
without necessarily killing the cells (227;228). Given its pore dependent nature, 
whether Ca2+ release from intracellular stores was due the to secondary pores 
formed was considered in membranes of intracellular organelles subsequent to entry 
of LLO into the cytosol via the primary LLO pores in the plasma membrane, was 
considered.  
The endoplasmic reticulum is the principal intracellular Ca2+ store. To test the above 
hypothesis, an experiment was designed that would allow to visually monitor whether 
LLO affects the ER directly. The ER-tracker BODIPY that accumulates in the ER 
lumen is a common tool for visualizing the ER in live cells. Because BODIPY leaks 
out of the ER in case of damage to the ER membrane, its retention within the ER 
lumen provides a means to evaluate the integrity of the ER. Therefore, to determine 
whether LLO perforates the ER, RBL-2H3 mast cells were loaded with ER-Tracker 
and then monitored for several minutes in the presence or absence of LLO. Upon 
treatment of cells with LLO, the ER was found to undergo rapid swelling 
accompanied by release of the ER-tracker (Figure 3.4A-B). This is in contrast to the 
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ER labelling of unstimulated cells, which was found to be steady throughout the time 
of image acquisition (Figure 3.4C-D). The Ca2+ ionophore ionomycin, which also 
induces Ca2+ influx as well as release from the intracellular stores, was however not 
found to release ER tracker from the ER (data not shown). Thus the LLO induced 
efflux of molecules from the ER was specifically due to the perforation of the ER by 
LLO.  
It is noteworthy to mention that, despite these remarkable effects, when fresh 
medium was added, most of the cells (almost 80%) recovered from the effects of LLO 
and could proliferate for several days thereafter. 
Taken together, these results suggest that LLO most likely penetrates the plasma 
and as well as the ER membranes to cause the release of ER components hence 
highlighting one of the mechanisms by which LLO, could release Ca2+ from 
intracellular stores. 
3.1.5 Prolonged LLO treatment leads to the depletion of 
intracellular Ca2+ stores  
Due to membrane repair mechanisms, cells treated with sublytic doses of toxin can 
fully recover. However, when cells were analysed for Ca2+ flux soon after treatment 
with LLO, surprisingly, it was observed that the LLO pretreated cells were refractory 
to calcium flux induction in response to LLO even in Ca2+ containing medium (Figure 
3.5A). 
A possible explanation for this phenomenon could be resistance of cells to 
membrane permeabilization. Such an effect was previously reported to be induced by 
pore forming agents (229). However, since pretreated cells were not resistant to 
propidium iodide uptake when re-treated with LLO (data not shown), resistance to 
permeabilization was ruled out as the cause of the diminished Ca2+ response. As 
shown earlier, the magnitude of Ca2+ response to LLO is a product of extracellular 
Ca2+ influx and release from intracellular stores. Having eliminated a decrease in 
Ca2+ influx, whether the above phenomenon was due to depleted intracellular Ca2+ 
stores was considered. 
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Figure 3.4. Perforation of the ER membrane by LLO causes the efflux of molecules from the ER 
lumen. To monitor release of molecules from the ER, the RBL-2H3 mast cells adhered on slides were 
loaded with the fluorescent ER-tracker. After washing, LLO was added to the cells and the efflux of ER 
tracker monitored for 40 min under a confocal microscope. The image in A and B shows the ER 
labeling in cells 30 sec and 40 min after addition of LLO respectively. C and D, respectively, show the 
labeling in untreated cells at the start (0 sec) and the end of a 40 min image acquisition.  
When the experiments described above were repeated in Ca2+ free medium, 
remarkably low calcium levels were observed in the LLO pretreated cells (Figure 
3.5B), an indication of depleted intracellular stores.  
Cross-linking of the high affinity receptor for IgE, FcεRI, on mast cells results in the 
activation of tyrosine kinases with the subsequent generation of inositol triphosphate 
(IP3), to trigger release of Ca2+ from internal stores. Therefore, to independently test 
the calcium depletion from the intracellular stores by LLO, calcium flux in response to 
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FcεRI cross-linking was tested. Again, as shown in Figure 3.5C, calcium release in 
response to FcεRI cross-linking was lower in LLO pretreated cells. In agreement, 
FcεRI cross-linking elicited almost no calcium response in cells pretreated with 
thapsigargin, an agent that also empties calcium from the intracellular stores. 
 
 
Figure 3.5. Pretreatment of cells with LLO for several hours depletes the intracellular Ca2+ 
stores thus rendering them refractory to subsequent stimulations. (A-C) After pretreating 
BMMCs with LLO or not for 4 h, cells were washed and loaded with Indo 1-AM. The elevation of 
cytosolic Ca2+ was evaluated in Ca2+ containing (A) and Ca2+free medium (B). (C) BMMCs were left 
untreated or pretreated with LLO or thapsigargin (a reagent that depletes intracellular Ca2+ stores) for 
4 h, loaded with Indo 1-AM then incubated on ice with with an IgE antibody specific for BSA-DNP. 
Cross-linking of the FcεRI was achieved by the addition of BSA-DNP. (D) Primary T cells pretreated 
with LLO for 4 h or 18 h to deplete the intracellular Ca2+ stores are refractory to Ca2+ induction by LLO. 
Cells pretreated (or untreated) with LLO for 4h or 18h were labeled with Indo-1-AM. Cytosolic Ca2+ 
elevation in such cells was then evaluated following their stimulation with LLO in Ca2+ free medium.  
To demonstrate that depletion of intracellular calcium stores by LLO is a property that 
can be generalized to other cell types, primary T cells were also tested. In Figure 
3.5D, untreated as well as T cells pretreated with LLO were re-stimulated with LLO in 
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Ca2+ free medium to assess only the Ca2+ released from intracellular stores. As 
shown before, calcium release from LLO-pretreated cells was remarkably lower than 
from untreated cells. Interestingly, almost no measurable calcium release was 
obtained with cells that were treated with LLO 4 h before measurement while cells 
treated 18 h earlier showed a low but definitive Ca2+ signal. This suggests that 
calcium depletion by LLO is reversible and that with time cells restock their 
intracellular Ca2+ stores. 
Taken together, LLO induces Ca2+ signalling via the influx from the extracellular 
milieu and release from intracellular stores. The uncontrolled release of Ca2+ from the 
intracellular stores leads their depletion hence rendering them refractory to 
subsequent stimulation. This could have important physiological consequences in the 
host`s response to Listeria infection.  
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3.2 Interaction of LLO with Lipid Rafts 
3.2.1 The role of cholesterol in the binding of LLO to plasma 
membranes 
Previous studies showed the requirement of cholesterol in the interaction of LLO with 
artificial membranes (66). As discussed in the introduction, cholesterol is the main 
stractural component of lipid rafts. Thus, to evaluate whether LLO interacts with rafts, 
flow cytometry was used to study the effect of filipin on the binding of a HA-tagged 
LLO (HA-LLO) to J774 macrophages. Filipin binds to and sequesters membrane 
cholesterol from other interactions, thus, disrupting cholesterol dependent membrane 
microdomains (95). As shown in Figure 3.6A, filipin pre-treated cells display a 
diminished capacity to bind HA-LLO. In further experiments, J774 cells treated with β-
methyl cyclodextrin (β-MCD), were tested for their capacity to bind HA-LLO. Unlike 
filipin, which only sequesters membrane cholesterol, β-MCD extracts cholesterol from 
plasma membranes. 
 
 
Figure 3.6. Depletion or sequestration of membrane cholesterol compromises HA-LLO binding 
to cells. J774 cells were treated with β-MCD or filipin (100 µg/ml in both cases) for 1h at 37°C before 
incubation with HA-LLO on ice. Cells were stained with biotinylated anti-HA antibody followed by 
streptavidin-PE then analysed by flow cytometry. The HA binding in represented as relative 
fluorescence intensity. 
As illustrated in Figure 3.6A, treatment of J774 cells with β-MCD resulted in a 
complete abrogation of HA-LLO binding. 
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3.2.2 LLO partitions into Detergent Resistant Membranes (DRMs) 
Cholesterol-rich microdomains or rafts are well recognised for their detergents 
insolubility - a property attributed in part to their cholesterol composition 
(111;230;231). Thus, if associated with rafts, cell bound LLO should partition into the 
detergent insoluble membrane fractions. J774 cells incubated with LLO were 
extracted with 1% Triton X-100 (on ice) and then subjected to ultracentrifugation on 
sucrose density gradients. Analysis of fractions by immunoblotting revealed that LLO 
preferentially partitioned into the DRMs that floated on the sucrose gradient (Figure 
3.7A).  
As discussed in the introduction, pre-incubation of LLO with cholesterol abrogates its 
cytolytic activity without compromising membrane binding (66). Therefore whether 
inactivated LLO also associates with the cholesterol-rich DRMs was investigated. 
Although CL-LLO exhibited a slightly different sedimentation pattern, the bulk of this 
toxin was also retained in the insoluble membrane fractions (Figure 3.7B). Further 
analysis revealed that the floating fractions were enriched in CD14 a GPI-anchored 
protein known for raft association (Figure 3.7A and B). In contrast, such fractions 
were depleted of the transferrin receptor (TFR), a membrane protein that is excluded 
from rafts (Figure 3.7A and B). 
To address whether the detergent insolubility and buoyancy exhibited by LLO/CL-
LLO is due to rafts association and not due to its intrinsic properties, LLO and CL-
LLO constituted either in the Triton X-100 or just in PBS buffer was fractionated on 
the gradient and analysed. Whereas LLO remained at the bottom of the gradient 
(Figure 3.7C, iii), CL-LLO was found to float on the gradient (Figure 3.7C iv and vi). 
The buoyancy of CL-LLO and membrane bound LLO (Figure 3.7Ci) was significantly 
decreased by the raft-disrupting detergent saponin (Figure 3.7Cii and v). Collectively, 
these results demonstrate that although LLO and CL-LLO might associate with 
membrane regions that fulfil the raft criteria of detergent insolubility and low 
buoyancy, complexing with cholesterol alone, whether in solution or in the cell 
membranes, is enough to impact such properties onto the toxin. 
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Figure 3.7. Membrane bound LLO and CL-LLO partition into the CD14 enriched Detergent 
Insoluble Membranes (DRMs). J774 cells treated with LLO (A), or CL-LLO (B) for 15 min at room 
temperature, were solubilized in 1% Triton X-100 on ice. The cell lysates were then fractionated on a 
16-40% step sucrose gradient by ultracentrifugation. 12 fractions collected from top to bottom of the 
gradient (fractions 1 to 12) were analysed by immunoblotting for the presence of LLO, CD14 and the 
transferrin receptor (TFR). For control, LLO was loaded in the lane marked C (A and B). C: Binding to 
cholesterol in solution confers detergent insolubility and buoyancy to LLO. J774 cells treated with LLO 
were solubilized in 1% Triton X-100 (i), or in a saponin lysis buffer (ii). In parallel, soluble LLO and CL-
LLO were also solubilized in either Triton X-100 (iii & iv respectively), saponin lysis buffer (v) or in PBS 
(vi). All the above preparations were then fractionated and the distribution pattern of LLO/CL-LLO in 
the sucrose gradient analysed as in A and B. 
3.2.3 Effect of LLO on the membrane distribution of raft associated 
molecules 
To corroborate on the interaction of LLO with lipid rafts, immunofluorescence was 
used to analyse the membrane distribution of a HA tagged LLO (HA-LLO) or its 
cholesterol-inactivated form (CL-HA-LLO) in relation to described raft associated 
molecules.  
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Figure 3.8. Clustering of GM1 by HA-LLO and CL-HA-LLO. J774 cells were treated with HA-LLO 
(A-C) or CL-HA-LLO (D-F) at RT and fixed in PFA before being labelled with CT-B. HA-LLO and CL-
HA-LLO binding is shown in red and CT-B binding in green, while yellow indicates a merge of the two 
signals. In G-I, cells were first incubated with filipin (100 µg/ml) for 1 h to sequester cholesterol before 
treatment with HA-LLO and CT-B as in A-C. J and K show the antibody controls for HA-LLO and CT-B 
staining, respectively. L shows the GM1 distribution on cells at basal conditions i.e. untreated cells 
fixed before incubation with CT-B. 
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Cholera toxin subunit B (CT-B), which labels the raft - associated gangliosides GM1, 
was chosen as a marker. When J774 cells were first incubated with HA-LLO or CL-
HA-LLO and fixed with paraformaldehyde (PFA) before labelling with CT-B, GM1 was 
found in clusters that extensively co-localized with those of HA-LLO or CL-HA-LLO 
(Figure 3.8A-F). This is in contrast to the uniform GM1 distribution observed on 
untreated cells (Figure 3.8L), and suggests that such clustering is induced by LLO. 
Antibody induced redistribution of proteins into patches if they are not properly cross-
linked with the fixative has been documented (232). To eliminate such a possibility, 
two fixation procedures have been used in this study, PFA and the PFA/Ac-MeOH 
fixation. The PFA/Ac-MeOH fixation procedure has been reported to be very effective 
in avoiding post staining aggregation (111;233). Here, as will be shown in the next 
figures, reproducible staining with respect to a dispersed distribution of rafts 
associated cell surface molecules was obtained with both procedures. One limitation 
observed with the PFA/Ac-MeOH fixation protocol is a high background staining, 
especially when using streptavidin based secondary reagents. Therefore, depending 
on the suitability of reagent combinations, either one of the two procedures has been 
employed in this study. Figure 3.9 shows the distribution of GM1 on cells fixed with 
PFA/Ac-MeOH, after HA-LLO treatment. Again, GM1 displays an extensive co-
clustering with HA-LLO under this condition. 
 
 
 
Figure 3.9. Co-clustering of GM1 with HA-LLO on PFA/Ac-MeOH fixed cells. J774 cells treated 
with HA-LLO were fixed with PFA/Ac-MeOH before labeling the GM1 with CT-B. Bound HA-LLO was 
revealed using a mouse anti-HA followed by Cy3-goat anti-mouse IgG (A) while CT-B was stained 
using goat anti-CT-B followed by donkey Cy2-donkey anti-goat (B). 
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To determine whether such co-clustering can be generalized to other raft-associated 
components, plasma membrane distribution of GPI-anchored proteins CD14, CD16 
and CD24 on J774 cells after LLO treatment also analysed. Figure 3.10 shows the 
distribution pattern of HA-LLO, CL-HA-LLO as well as CD14 on J774 cells fixed with 
PFA post toxin treatment. As predicted, CD14 also exhibits an extensive co-
clustering with HA-LLO or CL-HA-LLO (Figure 3.10A-F). Figure 3.10G-I displays the 
staining of HA-LLO and CD14 on J774 cells that were fixed in PFA before treatment 
with HA-LLO. No obvious clustering of LLO and CD14 was observed under these 
conditions. Thus, pre-fixation of membranes interferes with the ability of LLO to 
aggregate raft components.  
To determine the specificity of clustering by LLO, the membrane distribution of HA-
LLO and the non-raft marker transferrin receptor (TFR) on J774 cells was also 
analysed (Figure 3.10J-L). Although the TFR tends to exhibit some patchy 
distribution even under basal conditions (data not shown), the clear segregation of 
the LLO clusters from the TFR indicates that LLO neither associates with nor induces 
clustering of TFR. Similarly, Figure 3.11 shows the distribution pattern of CD14 and 
TFR in relation to HA-LLO on PFA/Ac-MeOH fixed cells. In this experiment, confocal 
microscopy was used to visualize and quantify the co-clustering of HA-LLO and 
CD14. The images shown in Figure 3.11C-E and F-H depict the distribution pattern of 
HA-LLO and CD14 viewed along the equatorial and polar planes of the same field, 
respectively. Unlike on untreated cells (Figure 3.11B), CD14 shows an extensive co-
clustering with HA-LLO (Figure 3.11C-H) while segregating from the TFR (Figure 
3.11J-L), as observed before. The fluorographs shown in Figure 3.11I-M display 
quantification of the co-localization between the HA-LLO and CD14 (Figure 3.11F-H) 
as well as TFR (Figure 3.11J-L) respectively. Clustering of other raft associated 
molecules such as CD16 and CD24 by LLO was also observed (Figure 3.12 and data 
not shown). 
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Figure 3.10. HA-LLO and CL-HA-LLO induce clustering of CD14 but not the TFR. The panels A-C 
and D-F display cells, first incubated with HA-LLO and CL-HA-LLO, respectively, before fixation. G-I 
shows HA-LLO and CD14 staining on cells fixed before HA-LLO treatment. J-L shows the HA-LLO 
and TFR staining on cells fixed after the HA-LLO treatment.  
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Figure 3.11. Quantification of co-localization between HA-LLO and CD14 or TFR. Cells treated 
with (or without) HA-LLO and fixed with PFA/Ac-MeOH, were stained for the bound toxin, CD14 as 
well as TFR before analysis by confocal microscopy. A and B show the anti-HA and CD14 staining on 
untreated cells. C-E and F-H depicts the distribution pattern of HA-LLO and CD14 viewed along the 
equatorial and polar planes of the same field, respectively. J-L shows the HA-LLO and TFR staining. 
HA-LLO was stained using mouse anti-HA and Cy3-anti-mouse IgG while CD14 was revealed using 
rat anti-CD14 and alexa488 coupled anti-rat-IgG. The co-localization fluorographs displayed in I and M 
show the intensities and scatter pattern of all pixels within the merged images H and L respectively. 
Pixels with mostly one fluorescent component are placed along the axes 1 and 2 while the pixels with 
equal fluorescence intensity from both components (due to co-localization) are placed along the 
diagonal. Axes 1 and 2, measured green and red fluorescence intensity of pixels on an arbitrary scale 
from 0 to 250. 
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Figure 3.12. HA-LLO induces co-clustering of CD16. Cells treated with HA-LLO were fixed with 
PFA/Ac-MeOH before staining for bound toxin and CD16. HA-LLO was revealed using a mouse anti-
HA followed by Cy3-goat anti-mouse IgG (B) while CD16 was stained using a rat anti-CD16 followed 
by Alexa488-goat anti-rat IgG (C). D is the merger of B and C while A shows the CD16 staining on 
untreated cells. 
3.2.4 Mechanism of rafts aggregation by LLO 
After binding to cholesterol on cell membranes, LLO monomers diffuse laterally to 
interact with each other to form oligomers. Since clustering of LLO or raft 
components is not observed under conditions in which lateral diffusion is blocked by 
prefixing membranes, it was hypothesized that such clustering is due to spontaneous 
oligomerization of membrane bound LLO monomers. 
To test this hypothesis, unfixed or prefixed cells treated with LLO or CL-LLO were 
analysed for the presence of oligomers by fractionation on sucrose gradients as 
previously described (66;225). Consistent with the prediction, the preponderance of 
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LLO as well as CL-LLO bound to unfixed cells was found to be in the high molecular 
weight oligomeric form (Figure 3.13 C and D). In contrast, LLO bound to prefixed 
cells remained largely in monomeric form (Figure 3.13E). Thus, the oligomerization of 
LLO and CL-LLO correlates with the clustering of the raft components by LLO. 
The neutralizing monoclonal antibody M344 which recognises a N-terminal epitope of 
LLO (between position 152-159) was proposed to block LLO oligomerization without 
inhibiting membrane binding (234).  
 
 
Figure 3.13. LLO does not oligomerize on prefixed membranes while neutralization with M344 
antibody blocks its oligomerization on unfixed membranes. Unfixed (C-G), or pre-fixed (E) J774 
cells were incubated for 10 min at RT with the following LLO formulations; the active LLO (C and E), 
CL-LLO (D), LLO neutralized with M344 antibody (LLO+M344) (F) or LLO+M344 additionally treated 
with cholesterol (CL-LLO+M344). After washing off unbound toxin, cells were solubilized in sodium 
deoxycholate, before fractionation on a continuous sucrose density gradient by ultracentrifugation. 
TCA precipitates of eleven equal fractions collected from top to bottom were analysed by 
immunoblotting for the presence of LLO. LLO monomers and oligomers are defined by their 
sedimentation behaviour in the gradient. Whereas the higher molecular weight LLO polymers 
sediment to the bottom of the gradient (fractions 8 -11), the lighter LLO monomers are mainly found at 
the top (fractions 1-7). Prior to membrane binding LLO and CL-LLO are mainly monomeric (A and B) 
but undergoe oligomerization on unfixed (C and D) but not prefixed (E) cell membranes. Pre-
incubation of LLO with M344 abrogates its subsequent oligomerization on unfixed membranes (F), 
which is however restored by the additional treatment with cholesterol (G). The LLO found in the high 
molecular fraction in A might be due spontaneous aggregations in solution akin to the phenomenon 
reported for SLO (235). The LLO found in the high molecular weight fraction in F is most likely due to 
incomplete neutralization by the antibody M344. 
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Figure 3.14. The neutralizing antibody M344 block rafts aggregation by HA-LLO but not by CL-
HA-LLO. J774 cells were incubated at RT with 1 µg/ml of the following LLO formulations; HA-LLO pre-
incubated with the non-neutralizing S179 antibody (HA-LLO+S179) (A-C), HA-LLO+S179 additionally 
treated with cholesterol (CL-HALLO+S179) (D-F), HA-LLO neutralized with M344 (HA-LLO+M344) (G-
I) or HA-LLO+M344 treated with cholesterol in addition (CL-HALLO+M344) (J-L). After washing off 
unbound toxin, cells were fixed with PFA before stained for the bound HA-LLO (red) and CD14 
(green). HA-LLO staining was done using a biotinylated anti-HA followed by Cy3-streptavidin.CD14 
was stained using a directly labeled FITC-anti-CD14. While brigher fluorescence signals due to local 
concentration of both molecules in the clusters can be observed where oligomerization occurred, 
dimmer fluorescence signals are obtained from the diffused LLO monomers and CD14 on cells despite 
the equal amount of bound LLO (flow cytometry data not shown). Scale bar, 5 µm. 
To explicitly demonstrate the role of LLO oligomerization in the aggregation of rafts, 
whether the M344 antibody could abrogate the co-clustering of rafts components by 
LLO was examined. To that end, HA-LLO or CL-HA-LLO were pre-incubated with the 
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neutralizing or non-neutralizing antibody before treating cells and evaluating the 
clustering of CD14. First, controls using the non-neutralizing antibody S179 show the 
aggregation of CD14 by HA-LLO and CL-HA-LLO as observed before (Figure 3.14 A-
F). 
In contrast, aggregation of CD14 was substantially inhibited when HA-LLO was 
neutralized with M344 (Figure 3.14G-I). Surprisingly, HA-LLO neutralized by M344 
could regain the ability to aggregate CD14 if additionally treated with cholesterol 
(Figure 3.14J-L). Analysis of extracts of cells treated with HA-LLO+M344 or CL-HA-
LLO+M344 for LLO oligomers confirmed that the M344 antibody indeed blocks 
oligomerization, which can nonetheless be restored by cholesterol treatment (Figure 
3.13F and G). 
3.2.5 LLO induces tyrosine phosphorylation in a raft aggregation 
dependent manner 
What is the functional significance of rafts aggregation by LLO? To address this 
question, the induction of tyrosine phosphorylation by LLO in J774 cells was 
evaluated. By immunoblotting it was observed that both LLO and CL-LLO induce 
tyrosine phosphorylation (112). Similarly, when analysed by immunofluorescence it 
was found that both HA-LLO and CL-HA-LLO could still induce tyrosine 
phosphorylation in the presence of the non-neutralizing isotype control antibody S179 
(Figure 3.15A-F). In contrast, but in agreement with oligomerization and rafts 
aggregation data (Figure 3.13 and Figure 3.14), neutralization with M344 abrogates 
the ability of HA-LLO to induce tyrosine phosphorylation (Figure 3.15G-I). This can 
however be restored by the additional treatment of the pre-formed LLO+M344 
complexes with cholesterol (Figure 3.15J-L), thus, demonstrating that the co-
clustering of raft components results in the induction of signals due to the 
oligomerization of membrane bound LLO monomers. 
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.  
Figure 3.15. The antibody M344 inhibits activation of tyrosine phosphorylation by HA-LLO but 
not CL-HALLO. J774 cells were incubated for 5 min at 37° C with 0.25 µg/ml of HA-LLO+S179 (A-C), 
CL-LLO+S179 (D-F), HA-LLO+M344 (G-I), or CL-HA-LLO+M344 (J-L). After washing, and fixation with 
PFA, cells were stained for surface bound toxin (red) after which they were permeabilized in 0.1% 
Triton X-100 then stained for phosphotyrosine (middle column). M-O shows the respective staining in 
the unstimulated control cells. Scale bar, 5 µm. 
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3.2.6 Activation of Lyn and Syk by LLO  
The src family kinase Lyn is anchored to the inner leaflet of the plasma membrane by 
way of myristate and palmitate chains that targets it to lipid rafts. To further elucidate 
the role of rafts aggregation in the induction of signalling whether Lyn also undergoes 
redistribution upon LLO treatment was investigated. Figure 3.16A shows that under 
basal conditions Lyn is uniformly distributed on the cell membrane. Upon treatment 
with HA-LLO an appreciable redistribution of Lyn into the LLO patches could be 
observed (Figure 3.16B-D).  
Whether LLO triggers redistribution of the cytoplasmic kinase Syk was also 
investigated. In this case however, no significant co-localisation of Syk with the LLO 
patches was observed (data not shown). 
Next the tyrosine phosphorylation status of these two kinases in response to LLO 
stimulation was investigated. J774 cells stimulated for the indicated durations (Figure 
3.16E) were lysed with cold 1% TritonX-100. The DRM and soluble materials 
(contained in the pellet and supernatant, respectively) were separated by 
centrifugation. Subsequently, representative samples of the DRM and soluble 
fractions were subjected to immunoprecipitation using an anti-phosphotyrosine 
antibody. The immunoprecipitates were then immunoblotted and developed with anti-
Lyn and anti-Syk antibodies. As evident from Figure 3.16E, both Lyn and Syk 
undergo a rapid tyrosine phosphorylation upon stimulation with LLO. As expected, 
Lyn was mainly enriched in the DRM while Syk was predominantly localised in the 
soluble fraction. A modest but transient recruitment of Syk to the DRM could however 
be observed (Figure 3.16E). 
It is noteworthy to mention that the tyrosine phosphorylation phase of these kinases 
upon LLO stimulation is quite transient. Prolonged stimulation (longer that 15 min) 
resulted in diminishing the phosphorylated form of these kinases (data not shown). 
This implies that, although activation of tyrosine kinases in macrophages by LLO 
might dominate the proximal signalling events induced, LLO also activates 
downstream negative regulators. 
In summary, the results presented show how, by aggregation of rafts via 
oligomerization, LLO causes the signal induction in target host cells. 
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Figure 3.16. Redistribution of Lyn into patches upon LLO treatment is accompanied by the 
activation of Lyn and Syk. Untreated (A) or HA-LLO treated cells (B-D) were fixed with PFA/Ac-
MeOH before staining for Lyn and bound toxin. E: Cells treated with HA-LLO for 2 and 4 min were 
lysed in ice cold 1% Triton-X 100. After centrifugation (20,000 g for 30 min), the supernatant (soluble) 
and the pellet (DRM) fractions were subjected to immunoprecipitation (IP) using the anti-
phosphotyrosine antibody (PY99). Subsequently, the IPs were immunoblotted and developed with 
anti-Lyn and-Syk antibodies. Lyn and Syk immunoblots of the pre-IP lysates are shown (bottom row). 
Scale bar, 5µm.  
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3.3 Role of mast cells in the control of Listeriosis 
As discussed in the introduction, mast cells are the first cell types in which evidence 
for the involvement of rafts in signaling was demonstrated. Recognition of antigen by 
specific IgE bound to FcεRI leads to the aggregation of FcεRI and hence its 
recruitment into rafts where signalling cascades that culminate in gene transcription 
and degranulation are initiated (140). As shown in section 3.1, calcium dependent 
processes regulate mast cells functions such as the spontaneous release of 
inflammatory mediators. Given that LLO triggers signalling in host cells via rafts as 
well as calcium signalling, mast cells were considered an ideal cell type for analysing 
the functional significance of signal induction by LLO during Listeria infection. 
As mentioned before, mast cells have largely been studied in the context of allergic 
diseases. However, their role in the control of pathogens is now well established 
(28;32;226;236;237). As partly outlined before, mast cells are endowed with several 
properties that place them in the frontline of host defences against invading 
pathogens. (1) They have a wide tissue distribution especially at the host-
environment interfaces such as the skin, airways and gastrointestinal tract, where 
pathogens, allergens and other environmental agents are frequently encountered 
(23). (2) In addition to de novo synthesis, mast cells have stored presynthesized 
inflammatory mediators thus being the most readily available source of such 
mediators during the early course of infection (238). (3) Mast cells can be activated 
by many different stimuli, acting via several signalling pathways, during innate and 
acquired immune responses (239). (4) They are long lived and can re-enter cell cycle 
and proliferate locally (23;239). 
Although a ready source of mediators and potentially being among the first cell types 
with which bacteria come into contact with, mast cells have so far not been 
investigated in the context of listeriosis. Thus, to assess the functional outcome of 
signals induced by LLO as well as live bacteria, in vitro and in vivo, mast cells were 
tested for their influence in the course infection by L. monocytogenes. 
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3.3.1 L. monocytogenes induces cytokine and chemokine 
transcription via LLO dependent and independent 
mechanisms 
In section 3.1.2 it was shown that both LLO and wild-type L. monocytogenes do 
induce degranulation as well as de novo synthesis of proinflammatory mediators 
such as TNF-α. To investigate further, the following questions with respect to the 
induction of cytokine and chemokine synthesis by LLO and whole bacteria were 
considered. (1) Does cholesterol inactivated LLO (CL-LLO) which does not form 
pores but aggregates rafts also induce cytokine /chemokine synthesis? (2) Is 
cytokine/chemokine synthesis by L. monocytogenes solely due to LLO or can other 
bacterial products induce such a response? (3) Since LLO also promotes the 
intracellular life cycle of L. monocytogenes, is the invasion of the cytosol by the 
bacteria required for the induction of the above responses? To address the above 
questions, bone marrow derived mast cells (BMMCs) were evaluated by RT-PCR for 
mRNA expression of TNF-α, Monocyte chemotactic protein-1 (MCP-1) and 
Macrophage inflammatory protein-1alpha (MIP-1α) in response to LLO, CL-LLO, 
wild-type L. monocytogenes (WTL.m), heat killed WTL.m (HKLWT) as well as the 
avirulent LLO deficient L. monocytogenes mutant strain (∆hlyL.m) or HKL∆hly. 
As shown before, the transcription of TNF- α was found to be induced by LLO but not 
by CL-LLO (Figure 3.17). Both, MIP-1α and MCP-1, genes were however found to be 
induced by LLO and CL-LLO suggesting that while the transcriptional activation of 
TNF- α largely dependents on the pore forming activity of LLO, signals induced by 
LLO via the non-pore dependent mechanisms are sufficient for the transcriptional 
activation of the MIP-1α and MCP-1 genes (Figure 3.17).  
In addition, both the WTL.m and ∆hlyL.m could induce a comparable transcription of 
these genes suggesting they can also be induced by listerial components 
independent of LLO. Interestingly, the TNF-α and MIP-1α genes could also be 
activated by the HKL preparations of WTL.m and ∆hlyL.m while MCP-1 apparently 
requires either LLO or viable Listeria. This indicated that neither LLO nor the invasion 
of the cytosol by the bacteria is essential for TNF-α and MIP-1α genes activation 
(Figure 3.17). Taken together, the data show that although LLO can directly induce 
the transcription of TNF-α, MIP-1α and MCP-1, such a response can also be induced 
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by other listerial products without necessarily infecting the cell. In fact, when BMMCs 
exposed for 3 h (the equivalent duration as for the above samples) to WTL.m and 
∆hlyL.m were analysed by electron microscopy, hardly any bacteria were found 
inside the cell. Despite, bacteria adhered to the cell surface (Figure 3.18). This is in 
stark contrast to the professional phagocytic cells J774 cells exposed to Listeria at 
the same multiplicity of infection (MOI) (data not shown). 
 
 
Figure 3.17. L. monocytogenes induces cytokine and chemokine transcription via LLO 
dependent and independent mechanisms. mRNA of TNF-α, MIP-1α, MCP-1 and the house 
keeping gene RPS9 in BMMCs at 3 h after exposure to the control medium (-Ctrl), WTL.m, HKLWT, 
∆hlyL.m, HKL∆hly, LLO or CL-LLO). Incubation of cells was done at a multiplicity of infection (bacteria 
: cell) of 100 while the predetermined sublytic LLO /CL-LLO concentration of 0.25 µg/ml was used. 
Noteworthy to mention also, there was no difference between the WTL.m and 
∆hlyL.m in their adherence to the mast cells surface. Therefore, although mast cells 
are known to have some phagocytic function (240;241), their phagocytic efficiency 
towards L. monocytogenes appears to be extremely low. By chance or design, 
fortunately, entry into these cells seems not be a requisite for the induction of 
cytokines and chemokines as demonstrated by the fact that they can be induced by 
HKL∆hly (Figure 3.17). 
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3.3.2 L. monocytogenes induces recruitment of neutrophils into 
the peritoneum via LLO dependent and independent 
mechanisms 
The early inflammatory response to infection with L. monocytogenes is characterized 
by the recruitment of granulocytes and monocytes to the site of infection - an 
essential requirement for control of infection. TNF- α, MCP-1 and MIP-1 α are among 
the key proinflammatory mediators, responsible for the attraction of such 
inflammatory cells to the sites of infection (15;16;19;242;243). 
 
  
Figure 3.18. Scanning electron micrograph of BMMCs incubated with ∆hlyL.m for 3 h. 
Thus, to evaluate the functional outcome of cytokine / chemokine induction, various 
preparations of L. monocytogenes and LLO were injected into the peritoneum of 
BALB/c mice. 1-3 hours later the peritoneal exudates were analysed for the 
recruitment of inflammatory cells. 
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Figure 3.19. L. monocytogenes induces recruitment of neutrophils into the peritoneum via LLO 
dependent and independent mechanisms. Mice were injected intraperitoneally with either of the 
following: medium control,  LLO (0.5 µg),  Cpd 40/80 (30 µg) or 1X105 of WTL.m, ∆hlyL.m and 
HKL∆hly. After 3 h peritoneal exudate cells were stained with FITC-anti-Gr1 and APC-anti-B220 and 
assessed by flow cytometry. Numbers represent the percentage of total cells found in the neutrophil 
(Gr1+) gate. 
3. Results  71 
Of the cell types analysed, neutrophils - an inflammatory cell type that plays a critical 
role in reducing bacterial burden in several organs (244) showed the most dramatic 
influx into the peritoneal cavity during this early period. Consistent with the induction 
of proinflammatory cytokines and chemokines, this response could be elicited by 
LLO, as well as live and HKLWT and ∆hlyL.m (Figure 3.19A-E and data not shown). 
3.3.3 Mast cells significantly contribute to the recruitment of 
neutrophils by LLO and L. monocytogenes 
Due to the pleiotropic effects of LLO and bacteria on host cells, as per the above 
experimental set-up, it was difficult to estimate the specific contribution of mast cells 
in the recruitment of neutrophils into the peritoneum. Thus, to specifically evaluate 
the role of mast cells activation, first, whether the mast cell specific activator 
compound 48/80 (Cpd 48/80) could also attract neutrophils was tested. Indeed as 
shown in Figure 3.19F, injection of Cpd 48/80 into the peritoneum induced a robust 
influx of neutrophils, indicating that mast cells activation by a mast cell specific 
stimulus was sufficient to induce the peritoneal influx of neutrophils in the peritonitis 
model employed. 
To definitively evaluate the specific contribution of mast cells, neutrophil recruitment 
was tested in mice depleted of mast cells by injecting the anti-c-Kit monoclonal 
antibody as previously described (223). Administration of the anti-c-Kit antibody as 
compared to a control antibody led to the depletion of over 90% of mast cells by 24 
hours post intraperitonial injection (Figure 3.20A-B).  
When mice were intraperitonially challenged with live WTL.m, mice depleted of mast 
cells showed a highly diminished capacity to recruit neutrophils compared to control 
mice (Figure 3.21A-D). This indicates that mast cells are definitively involved in the 
earliest anti-Listeria innate host reactions characterized by the influx of neutrophils to 
the site of infection. 
3.3.4 Accumulation of TNF- α in the peritoneal cavity of mice 
infected intraperitoneally with L. monocytogenes 
Next, an attempt was made to determine the mast cell product/s that regulated the 
recruitment of neutrophils. Focus was put on TNF-α. TNF-α was considered as a 
prime candidate for at least two reasons. (1) TNF-α is a known potent mediator of 
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neutrophils attraction to sites of inflammation (28). (2) As mentioned earlier, TNF- α is 
prestored in mast cell granules and is therefore spontaneously released when mast 
cells are exposed to bacteria or bacterial products such as LLO (as shown in section 
3.1.2). To determine whether mast cell activation by Listeria also leads to release of 
TNF-α in vivo, TNF-α concentration in the peritoneal cavity of normal and mast cell 
depleted mice was measured 3 hours after bacterial challenge. 
 
Figure 3.20. Depletion of mast cells in mice using anti-c-Kit antibody.  24 h after intraperitoneal 
injection of an isotype control antibody (A) or the mast cell-depleting antibody anti-c-Kit (B), mice were 
sacrificed and the peritoneal exudate cells stained with FITC-anti-FcεRI and APC-anti-c-Kit (mast cell 
surface markers) then assesed by flow cytometry. Mice injected with anti-c-Kit antibody (B) contained 
less than 10% of those injected with isotype control (A). 
As shown in Figure 3.22, a significantly higher concentration of TNF-α was found in 
the peritoneal exudates of infected mice. Consistent with a requirement for mast 
cells, diminished TNF-α levels were detected in mast cell-depleted mice (Figure 
3.22). This strongly suggests that mast cells are the major source of the TNF-α 
released in the very early stages of Listeria infection. 
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Figure 3.21. Mast cells significantly contribute to the intraperitoneal recruitment of neutrophils 
by LLO and L. monocytogenes. 24h after injection of the control (A & B) or the anti-c-Kit (C) 
antibodies, mice were infected with 1x105 WTL.m intraperitoneally. 3 h after infection the recruitment 
of neutrophils into the peritoneum was assessed by staining peritoneal exudate cells with FITC-anti-
Gr1 and APC-anti-B220. Each of the stainings shown are representative of peritoneal exudates of 
three mice. The absolute numbers of neutrophils in the peritoneum (three mice per group) are shown 
in D. 
Since mast cell dependent recruitment of neutrophils into the peritoneum appeared to 
correlate well with accumulation of TNF-α, whether TNF-α alone in the absence of 
Listeria infection could elicite a similar response was tested. Administration of TNF-α 
into the peritoneum of mice led to a rapid influx of neutrophils into the peritoneum, 
quite comparable to that triggered by administration of bacteria (Figure 3.23A-C). 
Taken together the above results show that the release of TNF-α by mast cells 
following activation by Listeria leads to the recruitment of neutrophils a major 
mediator of innate immunity. 
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Figure 3.22. Listeria induces accumulation of TNF in the peritoneal cavity in a mast cell 
dependent manner. Mice injected with an isotype control antibody or depleted of mast cells using the 
anti-c-Kit antibody were infected or not with 1x105 WTL.m intraperitoneally. After 3 h, mice were 
sacrificed and the peritoneum flushed with 10 ml of tissue culture medium. The washouts were then 
analyzed for the concentration of TNF. The bars represent the mean and standard deviation of three 
individually analyzed mice per group (* p<0.05). 
3.3.5 Mast cell dependent recruitment of neutrophils is required for 
listerial clearance 
The recruitment of neutrophils plays an important role in containing the bacteria at 
the site of infection hence curbing dissemination to other tissues (244). Accordingly, 
when neutrophils were depleted using the anti-granulocyte monoclonal antibody 
RB6-8C5, mice showed a profound deficiency in their innate immune response with 
the bacterial burden in the liver and spleen of such mice 2 days post infection. 
Compared to the undepleted controls, over 500 fold more Listeria organisms were 
recovered in the mice injected with RB6-8C5 antibody (Figure 3.24A-B). 
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Figure 3.23. TNF- α induces the recruitment of neutrophils into the peritoneum of mice. Mice 
were treated intraperitoneally with either 200 pg TNF- α, 1x105 WTL.m or the control medium. After 3 
h the peritoneal exudate cells were stained with FITC-anti-Gr1 and APC-anti-B220 to assess the 
recruitment of neutrophils. 
 
Figure 3.24. Neutrophils play an essential role in the resolution of L. monocytogenes infection. 
24 h after intraperitoneally administering an isotype control antibody or the neutrophil depleting RB6-
8C5 antibody, mice were challenged with 1x105 WTL.m via the intraperitoneal route. 3 days post 
infection mice were sacrificed and bacterial burden of the liver (A) and spleen (B) was determined. 
Circles represent individual mice, and bars represent geometric mean CFU/organ. 
In view of the fact that the recruitment of neutrophils to the site of infection was mast 
cells dependent, the next question was whether depletion of mast cells would also 
impair the ability of mice to combat Listeria infection. For that, mice were injected with 
either the anti-c-Kit antibody or an isotype control antibody. 24 h later they were 
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challenged intraperitoneally with L. monocytogenes. When analysed 3 days post 
infection, the bacterial burden in the livers and spleens of mast cells-depleted mice 
was found to be approx 200 fold and 500 fold, respectively that of mice injected with 
the control antibody (Figure 3.25A-B). 
Interestingly, the difference in bacterial burden in the peritoneum, between the 
control and mast cell depleted mice was very minimal (Figure 3.25C). Judged by the 
low cfus (colony forming units), the results show that the peritoneum although the site 
of bacterial inoculation is not the optimal organ for the replication of L. 
monocytogenes, rather the bacteria disseminate quickly to their major target organs - 
the spleen and liver. 
 
 
Figure 3.25. Mast cell depletion leads to an increase in susceptibility to L. monocytogenes 
infection. Normal (+Isotype control) and mast cell depleted (+anti-cKit) mice were infected with 1x105 
WTL.m intraperitoneally and sacrificed at day 3 post infection to determine the bacterial burden in the 
liver (A), spleen (B) and peritoneum (C). The circles, squares, and triangles represent individual mice 
while the bars represent the geometric mean cfu/organ. Note the different scales in the panels. 
In summary, the experiments described here show that in the sepsis model in which 
L. monocytogenes are injected in high doses intraperitoneally, mast cells have a 
significant role in the host defenses. Thus, mast cells, a cell type often associated 
with harmful hyper reactions such as allergy and autoimmune diseases, also have a 
definite beneficial function in the host in the combat against bacterial infections such 
as Listeriosis. Their strategic localization at the ports of entry of pathogens combined 
with the propensity to rapidly secrete a battery of proinflammatory mediators in 
response to several bacterial products, puts them at the frontline of the innate 
immune reactions critical for the effective control of bacterial infections such as 
Listeria.  
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3.4 Role of Toll-like receptors (TLR) in activation of mast 
cells by L. monocytogenes 
As discussed earlier, LLO is the main virulence factor of L. monocytogenes which 
without, the bacteria can neither survive nor generate a protective immune response 
(1). This could be attributed to its role in promoting the bacteria’s intracellular life 
cycle as well as the signals it induces in the host cells. The data presented above 
have defined calcium flux induction and lipid rafts aggregation as the mechanisms by 
which LLO triggers a variety host cell responses. In mast cells for instance, LLO 
triggers the release of a battery proinflammatory mediators such as TNF-α that 
induce the recruitment of neutrophils, the principal mediator L. monoctogenes 
clearance. As presented above however, LLO does not hold an absolute monopoly in 
signal induction by L. monocytogenes. The LLO deficient mutant (∆hlyL.m) as well as 
the HKL∆hly were found to induce cytokine /chemokine gene expression and hence 
the recruitment of neutrophils to the site of infection. This suggests that in the 
absence of LLO, other L. monocytogenes products can compensate for some of the 
LLO induced proinflammatory signals.  
As discussed earlier, Toll-like receptors (TLRs) transmit signals in response to 
microbial molecules that activate innate immune defences (199). TLR2, and TLR5 
have been implicated in the recognition of L. monocytogenes (214;217;245). TLR2 is 
involved in the recognition of bacterial peptidoglycan, lipoteichoic acid and 
lipoproteins, while TLR5 recognizes bacterial flagellins. Since lipoteichoic acid can 
also be recognized by the TLR4, it is possible that TLR4 could also be involved. In 
any case, LLO like the other cholesterol dependent cytolysin (CDCs) have also been 
suggested to be agonist of TLR4 signalling (219;220) making it all the more likely that 
L. monocytogenes also triggers host responses via the TLR4. 
3.4.1 Activation of NF-κB by L. monocytogenes 
NF-κB is the key transcription factor via which TLR signalling activates the 
transcription of proinflammatory cytokines and chemokines. In addition to other 
transcription factors such as NFAT as shown above, LLO has also been shown to 
activate NF-κB (77;82). This illustrates the ability of L. monocytogenes to trigger 
disparate signalling pathways that converge at NF-κB activation via multiple cell 
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surface receptors. This could explain the redundancy in proinflammatory signals 
induced by LLO and ∆hlyL.m. To investigate such a possibility, first, whether LLO 
and ∆hlyL.m induce NF-κB activation in the BMMCs was investigated. To that end, 
BMMCs were stimulated with either WTL.m, ∆hlyL.m, or LLO for 45 min, fixed, then 
subjected to immunoflourescence staining to evaluate the intracellular localization of 
the NF-κB isoforms p50, p52 and p65. All of the above stimuli were found to  induce 
nuclear transclocation of the already mentioned NF-κB isoforms. Figure 3.26 shows 
that NF-κBp50 and NF-κBp52 accumulate in the nuclei of cells stimulated with LLO 
and ∆hlyL.m but not the untreated control (bottom). A similar NF-κBp65 staining 
pattern was observed (data not shown). 
3.4.2 Role of TLR signaling in the activation of proinflammatory 
cytokines /chemokine genes 
Next, it was investigated whether the redundant proinflammatory signals induced by 
L. monocytogenes were due to NF-κB activation via the TLR signaling. For that, 
BMMCs from WT, MyD88-/-, TLR2-/-, TLR4-/-, and TLR2/4-/- mice were analyzed for 
their ability upregulate proinflammatory factors in response to WTL.m, ∆hlyL.m and 
LLO.  
Again, analysis was focused on TNF-α, MIP-1α and MCP-1, three of the main factors 
that play an essential role in the innate defences against Listeria.  
As shown earlier, RT-PCR analysis revealed that WTL.m, ∆hlyL.m and LLO do up 
regulate the mRNA of all of the above proinflammatory factors in the BMMCs from 
WT mice (Figure 3.27). Interestingly, both WTL.m and LLO but not ∆hlyL.m were 
found to induce these genes in the BMMCs from MyD88-/-, TLR4-/-, and TLR2/4-/- 
mice. (Figure 3.27). Although strong indications from analysis of TLR2-/- BMMCs 
suggest a similar gene activation pattern (data not shown), an accidental error is 
sample labelling necessitates a repeat of the experiment in order to ascertain those 
particular results. This was not possible within the time frame of this thesis. 
Notwithstanding the pending reanalysis of the TLR2-/- cells, the data presented herein 
do provide a basis for the following interpretation; L. monocytogenes activates TNF-
α, MIP-1α and MCP-1 genes via two independent signalling mechanisms; TLRs 
signalling and signal induction by LLO. 
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Figure 3.26. L. monocytogenes activates nuclear translocation of NF-κB via LLO dependent 
and independent mechanisms. BMMCs were incubated with (or without) either LLO (0.25 µg/ml) 
WTL.m or ∆hlyL.m (MOI 100) for 45 min, fixed, permeabilized and then stained with mouse anti-NF-
κBp52 and rabbit anti-NF-κB p50. Subsequently, the cells were incubated with Cy3-goat anti mouse 
(red) and Alexa488-goat anti-rabbit (green). The panel in the left show the NF-κB p52 staining, the 
middle show NF-κBp50 while the right show a merger of the signals. Cells stimulated with WTL.m 
showed a similar pattern of NF-κB nuclear accumulation to that observed in LLO and ∆hlyL.m treated 
cells. 
Thus in the absence of LLO, TLR signals do provide the proinflammatory signals 
induced by ∆hlyL.m in the WT cells whereas LLO provides the proinflammatory 
signals induced by WTL.m in TLRs deficient cells. This could explain why in the 
absence of both signals, ∆hlyL.m cannot induce gene activation in TLRs deficient 
mast cells. 
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Figure 3.27. Role of LLO and TLR signaling in cytokine and chemokine induction by L. 
monocytogenes. BMMCs from WT, MyD88-/-, TLR4-/- and TLR2/4-/- mice were incubated with either 
LLO (0.25ug/ml), WTL.m or ∆hlyL.m. After 3 h cells were analyzed RT-PCR for the mRNA of TNF- α, 
(A), MIP-1α (B), MCP-1 (C), and the house keping gene RSP9 (D). 
Thus, taken together, these experiments impressively demonstrate how a complex 
pathogen like L. monocytogenes influences its survival in the host by employing 
different virulence factors and other bacterial components to trigger multiple but 
sometimes redundant signalling pathways. 
 
 4 Discussion 
LLO is the main virulence factor of L. monocytogenes which without, the bacteria can 
neither survive nor generate a protective immune response. This could be attributed 
to its role in promoting the bacteria´s  intracellular life cycle as well as the signals it 
induces in the host cells. The aims of the present study were to delineate the 
mechanisms of signal induction by LLO and to understand the significance of such 
signals in vivo during Listeria infection.  
LLO can trigger signal in host cells via pore dependent and pore independent 
mechanisms. The present studies have defined calcium flux induction and lipid rafts 
aggregation as the pore dependent and pore independent mechanisms respectively, 
via which LLO triggers a variety host cell responses. To understand better the 
functional significance of signal induction by LLO, for most of the studies, focus was 
laid on mast cells, a cell type so far not investigated in the context of Listeria 
infection. In this cell type, LLO was found to triggers the release of battery 
proinflammatory mediators such as TNF-α that induce the recruitment of neutrophils, 
the principal mediator L. monocytogenes clearance. These findings have culminated 
in identifying mast cells as being a key player in the innate immune responses 
against Listeriosis. In addition to elucidating the mechanisms and role of LLO, effort 
was also extended towards understanding the role of TLRs in signal induction by L. 
monocytogenes. Initial data indicate that by triggering analogous signalling pathways, 
LLO and other listerial components that engage TLRs could compensate for each 
other in the induction innate proinflammatory reactions. The main highlights of the 
present findings are discussed in more details below. 
4.1 The Influx and Efflux of Ca2+ induced by LLO in target 
cells- the consequence of double membrane 
perforation 
In the present study, LLO, a member of the CDCs, was shown to cause the influx as 
well as the release of Ca2+ from the intracellular stores. As envisioned in the model 
presented in Figure 4.1, Ca2+ release from the intracellular stores might be due to the 
perforation of the ER membrane by LLO following the influx of LLO monomers via the 
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primary plasma membrane pores. The self-delivery of LLO into the cytosol has 
previously been shown (227). Although the possibility that LLO transported in 
endocytic vesicles via the retrograde transport could be delivered to the ER to cause 
Ca2+ release cannot also be excluded, the assumption of cytosolic LLO diffusing 
passively to the ER membrane appears to be more straightforward.  
 
 
Figure 4.1. Schematic illustration of how LLO doubly penetrates the plasma and the 
intracellular membranes to cause the influx of Ca2+ as well as its release from intracellular 
stores. LLO monomers bind to the cell membrane and assemble into oligomeric pores large enough 
to allow the passage of smalls ions such as Ca2+ and proteins. The entry of LLO monomers into the 
cytosol via the primary transmembrane LLO pores subsequently lead to their assembly into pores on 
the cholesterol-rich internal membranes such as the ER. Whereas the release of intracellularly stored 
Ca2+ via these internal pores can trigger cellular responses such as cytokine induction, its sustained 
efflux due a prolonged incubation with LLO eventually leads to depletion of intracellularly stored Ca2+.  
The cytosolic delivery of LLO via a self-delivery mode is reminiscent of the ‘type III’ 
secretion system used by Gram-negative bacteria to deliver bacterial virulence 
factors into host cells. This view is in fact in concordance with the recent suggestion 
that cholesterol dependent cytolysins (CDCs) could be an analogous system in 
Gram-positive bacteria enabling them to deliver virulence factors into host cells (87). 
In this respect, the cytosolic delivery of PI-PLC, another virulence factor of L. 
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monocytogenes which also triggers Ca2+ release from intracellular stores, but via the 
generation of IP3, is also mediated by LLO (88).  
Induction of Ca2+ signals by L. monocytogenes in target cells is very important in the 
context of bacterial survival in the host. Ca2+ induction by LLO facilitates bacterial 
uptake in epithelial cells (71) while inhibiting uptake by macrophages (88). This 
illustrates how the pathogen strategically manipulates Ca2+ induction to maximize 
entry into the host via the epithelia, but minimizing its phagocytosis by bactericidal 
macrophages.  
As demonstrated in this work for mast cells, Ca2+ induced by LLO can trigger the de 
novo synthesis and secretion of preformed proinflammatory mediators. This could 
facilitate bacterial spreading by recruiting more potential host cells to the site of 
infection. Similarly, other effects observed during Listeria infection like, induction of 
apoptosis in spleen or liver cells, might also involve Ca2+ fluxes induced by LLO 
(42;43). 
While the current data do not rule out other mechanisms such as Ca2+ channels, the 
current data do at least suggest that release of Ca2+ from intracellular stores is most 
probably due to the passive efflux from the ER via the toxin pores. This uncontrolled 
release ultimately leads to the depletion of Ca2+ from such stores. Hence, cells pre-
exposed to LLO are refractory to subsequent Ca2+ inductions. Depletion of 
intracellular Ca2+ stores in host cells may have important physiological significance in 
the context of listeriosis. The productive activation of lymphoytes requires a balanced 
integration of Ca2+ and other signalling pathways while stimulation of the antigen 
receptor in the absence of Ca2+ signalling or the vice versa, leads to anergy (246). 
Accordingly, when subjected to a sustained exposure to the Ca2+ ionophore 
ionomycin (an agent also known to deplete intracellular Ca2+ stores), T cells not only 
become refractory to subsequent Ca2+ induction via the antigen receptor, but 
generally exhibit an anergic state (247). In light of the present findings, it is 
imaginable that during Listeria infection, a prolonged exposure of host lymphocytes 
to LLO could render such cells unresponsive to stimulation, thus undermining the 
host’s ability to mount an effective immune response, much to the pathogen’s 
advantage.  
That LLO doubly penetrates the plasma and the internal membranes provides a new 
perspective in our understanding of how the CDCs affect target cells. In fact, the 
implications thereof stretch far beyond the release of intracellular Ca2+ release as 
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shown in this study. Based on the current as well as other published findings (87;88), 
it would not be entirely groundless to speculate that LLO secreted by the intracellular 
bacteria probably also mediate the delivery of virulence factors into the cholesterol 
containing intracellular organelles, thereby modifying their functions.  
Over time, cells can repair membrane lesions (248). Indeed, it was observed, that 
cells could recover from toxin attack and even restock the intracellular Ca2+ stores. 
Thus, LLO and the other CDCs provide attractive prospects in cell biology not only for 
introducing molecules into cells, but also for studying or manipulating Ca2+ regulated 
processes. 
In conclusion, the data in this study provide a novel paradigm for the CDCs with 
important implications in the understanding of how these toxins contribute to the 
pathogenesis in their respective hosts. 
4.2 LLO induces signalling in host cells via the 
aggregation of lipid rafts 
In this part of the study, the co-aggregation of different rafts components was 
revealed as the second novel mechanism by which LLO triggers signalling in host 
cells. As illustrated in the proposed model below (Figure 4.2), rafts’ clustering is due 
to oligomerization of membrane cholesterol bound toxin monomers. By using a 
cholesterol pre-inactivated form of LLO (CL-LLO) it was also demonstrate that LLO 
does activate tyrosine kinases in a pore independent manner.  
Pore independent aggregation of rafts LLO is of important physiological significance 
in the context of listeriosis. In vivo, most of the LLO secreted into physiological fluids 
by extracellular bacteria or ruptured infected cells is most likely rapidly inactivated by 
blood borne cholesterol thus abrogating its ability to form pores as well as to trigger 
signals via such a mechanism. Therefore, the ability of CL-LLO to aggregate rafts 
guarantees that despite the loss of pore formation, the toxin can still trigger different 
cell-type specific responses, which ultimately influence the course of infection as 
discussed earlier.  
Raft aggregation could also help to explain the differential signals induced by LLO in 
the various host cells. Since the signalling molecules associated with rafts differ from 
one cell type to the other, it is hereby hypothesized that the composition of rafts could 
dictate the cell type specific signals triggered by LLO. Thus as shown for Lyn in the 
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J774 macrophage line, LLO probably induces signalling in different cell types via the 
dominant rafts associated receptors, kinases and adaptors. 
 
 
Figure 4.2. Model for rafts and signal transduction by LLO. LLO either binds directly to the 
cholesterol in rafts or is indirectly targeted to rafts by the cholesterol bound in solution. The 
oligomerization of rafts-associated toxin monomers (40–80), then results in the clustering of rafts 
leading to signal induction. The raft clusters formed thereof are large and can be visualized easily by 
light microscopy. 
The results herein presented also have a number of implications for the role of 
cholesterol during the interaction of LLO (or CDCs in general) with the target 
membrane. The oligomerization and raft clustering data show that the cholesterol 
pre-inactivation step does not inhibit its subsequent oligomerization on target 
membranes. This finding was rather unexpected in face of electron microscopic 
observations from our laboratory documenting the absence of arc or ring shaped 
structures on erythrocyte ghosts treated with CL-LLO (66). The simplest explanation 
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that may reconcile these observations is that, whereas oligomerization and 
membrane insertion of LLO results in the formation of functional pores readily visible 
as arc or ring structures, oligomerization of CL-LLO on the other hand results in the 
formation of clandestine non-lytic oligomers probably similar to the streptolysin O 
(SLO) non-lytic oligomers (225) or the perfringolysin O (PFO) prepore complexes 
(249). One of the functions of cholesterol in the interaction of CDCs with target 
membranes is the induction of a conformational transition necessary for membrane 
insertion (250;251). It therefore seems feasible that in the aqueous environment, 
cholesterol triggers the toxin to adopt a faulty conformation, which although still 
capable of self-aggregation, cannot subsequently insert into the non-polar lipid 
bilayer. 
In addition to demonstrating the role of LLO oligomerization on raft clustering and 
signalling, the data confirm a previous study that predicted the involvement of regions 
in the N terminal domain 1 in toxin oligomerization (234). However, the surprising 
finding that the treatment of the antibody neutralized LLO with cholesterol results in 
the restoration of oligomerization and hence rafts’ clustering (Figure 3.13 and Figure 
3.14), highlights an additional role of cholesterol in the complex process of 
oligomerization. First, it suggests that other self-aggregation sites do exist, and 
secondly, that self-aggregation via such sites is dependent on the conformational 
transitions triggered in the toxin monomers by cholesterol. Data based on proteolytic 
and recombinant fragments suggesting self-aggregation sites in the C-terminal half of 
the CDCs (252;253), are in keeping with the present finding, as are data showing that 
interaction with cholesterol triggers major conformational changes in the monomers 
that facilitates oligomerization and membrane insertion (250;251;254). 
How does CL-LLO aggregates rafts’ components? It is known from model membrane 
systems that due to Van der Waal forces, cholesterol and other saturated lipids tend 
to preferentially assemble into the hydrophobic lipid ordered microdomains as 
compared to the non raft matrix of the membrane (85). Thus, upon adsorption into 
the membrane, cholesterol exogenously introduced as a complex with LLO (i.e. CL-
LLO) also partitions into rafts domains where the subsequent oligomerization of the 
bound LLO ultimately leads to the aggregation of not only cholesterol but other rafts 
components indirectly associated with it as well. 
Co-clustering of raft components due to toxin oligomerization is probably not 
restricted to LLO or members of the CDCs as such. The recent findings that the 
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heptamerizing toxin aerolysin (183) does also co-cluster different GPI-anchored 
proteins (109) suggests that other oligomerizing toxins that engage receptors in lipid 
rafts probably also induce rafts` clustering. It however remains to be shown whether 
co-clustering by other toxins is only limited to their receptors (e.g. the GPI- anchored 
proteins in the case of aerolysin) or whether that also extends to the other indirectly 
associated rafts´ components as herein shown for LLO. In addition, the oligomeric 
complexes formed by CDCs are generally larger than those of any other toxins 
studied so far. Thus, the extent of rafts` clustering by such toxins probably pales in 
comparison to that by the CDCs. 
In conclusion, the present study provide evidence that LLO is a potent inducer of raft 
aggregation, which might provide one of the molecular explanations for the broad 
host cell responses, mediated by LLO during Listeria infection. The findings could 
also provide a general paradigm of how other CDCs might interact with target cells. 
Equally important, the findings herein demonstrate the potential application of LLO in 
studying the biology and composition of rafts. Although lipid rafts have been 
implicated in a variety of biological functions (94;95), their structure, with respect to 
size and composition is still uncertain. Recent studies based on single particle 
tracking (255) and fluorescence resonance energy transfer (FRET) (109;110;256) 
methods have placed the size of rafts at a nanometer range explaining why native 
rafts have eluded detection by standard light microscopy. Thus microscopical 
visualization of rafts has only been accomplished after aggregating rafts` components 
like by the use of antibodies (110;111). However, owing to the tendency of raft 
components to segregate into distinct raft sub-types, attempts to use antibodies for 
the co-clustering of different rafts components have largely been unsuccessful 
(109;110;257). Thus, since LLO indiscriminately co-clusters of rafts` components by 
aggregating membrane cholesterol (the universal “glue” of rafts), it could therefore be 
used to visualize rafts and hence identify putative rafts component as well as 
signalling pathways mediated via rafts. 
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4.3 Role of mast cells in the control of L. monocytogenes 
infection 
The functional significance of signal induction by LLO was investigated in mast cells. 
LLO was found to induce two important responses in this cell type (1) rapid secretion 
of pre-sythesized stored inflammatory mediators via degranulation and (2) de novo 
synthesis of such mediators. Using a Listeria septic peritonitis model, the data herein 
presented show that the secreted mast cell products especially those with neutrophil 
chemo-attractive properties play a critical role in host defence against L. 
monocytogenes. The specific contribution of mast cells to the anti-Listeria innate 
immune defence was demonstrated by the depletion of mast cells using a 
monoclonal antibody against c-Kit, a protein highly expressed on mast cells. Mast cell 
depleted mice showed a significantly diminished capacity to attract neutrophils 
following intraperitoneal challenge with L. monocytogenes. As previously shown for 
other bacterial pathogens (32), these recruited neutrophils were found to be critical 
for early clearance of bacteria at the site on infection thus limiting dissemination to 
other organs such as the liver and spleen. In these organs, the number of Listeria in 
the mast cell depleted mice was found to be more that 2 logs higher as compared to 
the undepleted controls. These data are highly consistent with findings from other 
models of infectious peritonis using the mast cell deficient W/Wv mice (28;32)  
Efforts to understand the mast cell secretory products that orchestrate the rapid 
recruitment of neutrophils into the peritoneum led to the identification of TNF-α. Of 
the multiple chemo-attractants that can be released by mast cells, TNF- α was 
considered of special interest because it is one of the presynthesized mediators 
stored in the mast cell granules hence is rapidly released upon activation 
(30;237;238;258). Accordingly, inoculation of L.monocytogenes into the peritoneum 
was found to induce a rapid accumulation of TNF-α in the peritoneal cavity in a mast 
cell dependent manner. Administration of TNF-α alone into the peritoneum induced a 
rapid influx of neutrophils thus confirming the direct role of TNF-α in such a response. 
That being the case however, it must be emphasized that these findings do not rule 
out the involvement of other mast cell derived neutrophil chemoattractants. Indeed 
TNF-α, may act in an auto/paracrine fashion and stimulate release of other 
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chemokines such as macrophage inflammatory protein 2 (MIP-2), or IL8 – also potent 
neutrophils chemoattractants (259). Additionally, TNF-α can facilitate neutrophil 
extravasation through endothelial walls by triggering endothelial cell expression of 
various cell adhesion molecules such as endothelial-leukocyte adhesion molecule 
(ELAM)-1 (30;31;240;260). TNF-α is also known to enhance the bactericidal activities 
of neutrophils (239).  
Besides controlling bacterial infection via neutrophils, mast cells can also control 
bacteria via direct mechanisms. Mast cells are also known to bind to and 
phagocytose bacteria (261) and release anti microbial peptides (262;263). Electron 
microscopic evaluation showed that compared to macrophages, internalisation of 
Listeria by BMMCs is extremely poor. This suggests that phagocytosis plays a minor 
role in listerial clearance. 
Although the present findings unequivocally show that mast cells play a critical role in 
host defence against L. monocytogenes infection, they are slightly at odd with one of 
the recent findings. The recent study by Edelson et al (264) using the mast cell 
deficient W/Wv mice found identical Listeria burdens in both spleens and livers of 
W/Wv and mast cell reconstituted W/Wv mice. Interestingly, and consistent with the 
present findings however, mast cells were demonstrated to play an important role in 
the recruitment of neutrophils into the peritoneum in response to Listeria. A number 
of reasons could be responsible for these disparate findings. First, the difference in 
the infection dose and the genetic background of the mice used. In the present study 
an intraperitoneal dose of 1x105 Listeria/mouse compared to 5x104 in that particular 
study. Although these doses may not be very different per se, it has to be borne in 
mind that compared to the BALB/c mice employed in the present study the C57BL/6 
X 129/Sv background of W/Wv mice is highly resistant to Listeria infection. Secondly, 
the intrinsic difference in the two systems i.e reconstitution of mast cell deficient mice 
verses depletion of mast cells could influence the ultimate readout of the mast cell 
function under evaluation. For instance, as opposed to the high efficiency of mast cell 
depletion (over 90 %) in the present study, the fact that reconstituted mice contained 
only 10 to 20% of the normal peritoneal mast cells numbers could in part account for 
the modest mast cell-dependent anti-Listeria host defence observed in that particular 
study. 
In summary, the data presented herein show for the first time that mast cells, a cell 
type often renowned for its distressing contribution to chronic inflammatory diseases 
4. Discussion  90 
(e.g, asthma) also has a primary role in the innate immune defences against L. 
monocytogenes. 
4.4 Role of TLRs signalling in the activation of mast cells 
by L. monocytogenes 
The overall activation of host cells by complex pathogens such as L. monocytogenes 
clearly involves the coordinated and often redundant activation of signalling pathways 
by several bacterial components. Thus it is difficult to ascertain the specific 
contribution of a particular product by analysing the host response to the whole 
organism. This is best illustrated by the fact that cytokine and chemokine expression 
and the consequential recruitment of inflammatory cells could be induced 
independently by LLO and ∆hlyL.m. As discussed above L. monocytogenes can 
induce signalling in host cells via TLRs such as TLR2, TLR4, TLR5, TLR6 and TLR9 
(213;216-218;245). Evaluation of mast cells from MyD88-/-, TLR2-/-, TLR4-/- and 
double TLR2/4-/- showed that while these receptors seem to play a role in cytokine 
and chemokine transcriptional activation by ∆hlyLm, apparently they are dispensable 
in the induction of such a response by WTL.m and LLO. This means that at least in 
mast cells, LLO and other listerial components that engage the TLRs, trigger 
redundant proinflammatory signals. Based on the present data by which LLO and 
∆hlyL.m were shown to induce the activation of NF-κB, a master regulator of several 
proinflammatory genes, it is tempting to hypothesize that the redundancy in the 
proinflammatory responses induced by LLO and ∆hlyL.m is in part due to the 
convergence of signalling pathways activated by these stimuli. In addition to NF-κB, 
activation of the transcription factor AP-1 via the MAPK signalling pathways is also a 
potential common point of convergence between signal induction by LLO and 
∆hlyL.m. This is supported by the several finding showing LLO and signal induction 
via TLRs can also activate this pathways (68;69;197;265). 
Redundancy in the induction of proinflammatory responses in host cells by  L. 
monocytogenes, and the possibility thereof that the proinflammatory signals triggered 
via the TLRs could be compensated for by other listerial products such as LLO, may 
help to explain the controversial findings with respect to the role of TLR2 in the host 
defence against Gram-positive bateria that secrete CDCs (213;214;245;266-268). 
Although there abundant evidence from in vitro observations that TLR2 is the 
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predominant receptor signalling the presence of cell wall components of Gram-
positive bacteria, such as peptidoglycan or lipoteichoic acid, data that confirm these 
observations in vivo are still scarce. In the case of L. monocytogenes, studies carried 
so far suggest that it is either dispensable or that its contribution to the control of 
Listeria is only modest (213;214;245). Similarly, a recent study has shown that TLR2 
does not importantly contribute to host defence in the Strepococcus pneumoniae. To 
add on to the complexity of the role of TLRs in the innate immune responses to 
Gram- positive bacteria, recent studies have reported that the CDCs signal via TLR4 
(219;220). Hence TLR4 mutant mice demonstrated an increased mortality when 
infected with wild type but not pneumolysin deficient pneumococci. 
Efforts are currently underway to investigate the signalling pathways common to LLO 
and TLRs and how this redundancy in the activation of proinflammatory signals by 
LLO and TLR ligands contributes to the overall host defences against Listeria.  
Taken together the present study add several novel findings on how L. 
monocytogenes interacts with its host which should spark off a plethora of further 
experiments that should finally lead to systems biology of listeriosis. 
 5 Summary 
The Gram-positive bacteria Listeria monocytogenes is the food borne etiological 
agent of Listeriosis whose manifestations include septicemia, meningitis, encephalitis 
and abortions in humans and livestock. The ability of L. monocytogenes to infect and 
survive in a wide range of animal species is attributed to several virulence factors 
which enables it to infect and proliferate in a variety of host cells. The pore-forming 
toxin, Listeriolysin O (LLO), is considered to be the most important virulence factor of 
L. monocytogenes. In addition to playing the essential role of allowing the bacteria to 
cross membrane barriers during its intracellular life cycle, LLO also act as a pseudo 
cytokine / chemokine, which induces a broad spectrum of host responses that 
ultimately influences the outcome of listeriosis. How LLO triggers signalling in host 
cells has been a subject of intense debate. It is now clear that LLO can trigger 
signalling in the host cell via pore dependent and pore independent mechanisms. 
The present data show that the pore dependent mechanism of signal induction by 
LLO is in part due its ability to cause influx of extracellular Ca2+ as well as release 
from intracellular stores in host cells. The data presented suggest that LLO 
accomplishes this by first forming transmembrane LLO pores which then allow influx 
of Ca2+ as well as LLO molecules into the cytosol. The cytosolic LLO molecules then 
form secondary pores in membranes of internal organelles such as the endoplasmic 
reticulum to cause the release of the intracellularly stored Ca2+.  
Secondly, the present study shows that the pore independent mechanism of signal 
induction by LLO is due to the aggregation the lipid rafts and their associated 
signalling molecules. Since cholesterol is the main structural component of lipid rafts, 
the cholesterol dependent cytolysin LLO binds to cholesterol in such membrane 
microdomains and spontaneously aggregates them as a result of oligomerization.  
The functional significance of signalling by LLO was evaluated in mast cells. The in 
vitro and in vivo data presented show that LLO induces the spontaneous release of 
presynthesized proinflammatory factors as well as their de novo synthesis. It is herein 
shown that the release of such proinflammatory mediators following activation of 
mast cells by LLO or L. monocytogenes triggers robust innate host reactions 
necessary for the control of Listeria infection. As a result of these finding it herein 
shown for the first time that mast cells, a cell type renowned for allergic and 
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autoimmune reactions also plays an important role in the control L. monocytogenes 
infection. 
To gain a more wholesome understanding of the mechanisms of signal induction by 
the whole organism, in the present work, the role of Toll-like receptors (TLRs) in the 
proinflammatory signals by L. monogytogenes was also evaluated. The findings 
indicate a redundancy in the proinflammatory signals induced by LLO and other 
listerial components that signal via the TLRs. Thus, although listerial cell wall 
components do trigger signalling via TLRs, such signals seem to be dispensable as 
they can be compensate for by LLO. These findings could help to reconcile the 
several controversial findings with respect to the role of TLRs in the innate immune 
reactions against Gram-postive bacteria that express cholesterol dependent 
cytolysins such as LLO. 
In overall, the findings impressively demonstrate how a complex pathogen like L. 
monocytogenes influences its survival in the host by employing different factors to 
trigger multiple but sometimes redundant signaling pathways. 
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